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ABSTRACT
The staphylococcal superantigen-like proteins (SSLs) are a family of polymorphic 
paralogs encoded within the Staphylococcus aureus genome, whose function remains 
unknown. The ability of SSL7, and a closely related paralog SSL9, to interact with cells 
of the immune system was investigated. Within the populations of human white blood 
cells, both SSLs interact selectively with monocytes, via specific but separate binding 
sites, leading to rapid uptake of SSLs. In addition, SSLs are rapidly taken up by dendritic 
cells (DC), but not macrophages, and target the mannose-receptor dependent endosomal 
antigen processing pathway. The effect of these proteins on the functional capacity of 
antigen presenting cells to uptake and present antigens to T cells was also determined. 
Neither SSL was toxic to DCs and the presence of SSL protein did not inhibit the antigen 
presenting cell activity, in terms of stimulation of either allogeneic or recall T cell 
responses. The immunological response to the SSL proteins in the normal human 
population was investigated. More than 30% of healthy normal subjects tested showed T 
cell responses to both SSL7 and SSL9. Moreover, almost all individuals had specific non­
cross reacting antibodies against this family of proteins. In order to identify the SSL 
receptor(s), affinity chromatography techniques were used to isolate and identify the 
receptor(s) from selected cell lines. A single specific protein band that may represent the 
putative SSL receptor was observed, and mass spectrometry identified a candidate binding 
protein as heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa, GRP78 (BiP)). 
The presence of eleven members of this protein family within the pathogenicity island 
SaPIn2 in almost all S. aureus strains tested so far, suggest that these proteins have 
important non-redundant biological functions as agents of host/pathogen interactions. 
The data presented in this thesis further suggests that this function may involve targeting 
the host antigen presenting cell.
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Chapter 1 General Introduction
1. Introduction
1.1. Immunity to bacterial infection
1.1.1. Host/Microbial interaction
A pathogen is an organism that can overcome the defence mechanisms of the body and 
induce deleterious changes in the host. Protective mechanisms are a series of systems 
which either confine the micro-organisms to the mucosal or skin surfaces, preventing 
access to the tissues of the body or, if the organism evades these outer defences, then there 
are systems that detect, confine and eliminate the invader (Basset et al., 2003). The host- 
microbial relationship is a dynamic process in which the microbe attempts to minimize its 
visibility, to insure survival, whereas the host attempts to prevent and eradicate infection 
with minimal damage to self (Palucka and Banchereau, 2002).
Antimicrobial protection is ensured by the coordinated action of the innate and adaptive 
immune systems (Janeway, Jr. and Medzhitov, 2002). The innate immune system is 
composed of two elements: cells such as epithelial cells, neutrophils, natural killer (NK) 
cells, macrophages and dendritic cells (DCs); and, proteins such as cytokines that are 
produced by the cells of the immune system or proteins such as complement factors that 
are produced by nonimmune cells (Palucka and Banchereau, 2002).
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Interaction of the host with the bacteria occurs at three levels: the extra-epithelial, 
epithelial and sub-epithelial level (Basset et al., 2003). The first line of defence is the 
epithelial surfaces of the airways and gastrointestinal tract, which face a mixture of mostly 
non-pathogenic bacteria from food, commensal microbes, and some pathogenic bacteria. 
In the airways, the majority of the microbes are removed by the overlying mucociliary 
escalator. Furthermore, respiratory epithelia are coated with a thin layer of secretions, 
which contain antimicrobial agents, for example lysozyme and defensins (Ganz, 2002). 
Another level of protection is provided by the tight junctions that connect the epithelial 
cells, forming a strong barrier that prevents the entry of microbes and their products. 
However, bacterial binding to the epithelium triggers a series of alarm signals resulting in 
the secretion of chemokines to recruit other components of the innate system, leading to 
the development of an acute inflammatory reaction (Basset et al., 2003). A small 
proportion of incoming microbes that enter at sites of micro-lesions is then handled by 
antigen-presenting cells (APCs), which are mostly DCs. Thus, when a pathogen invades a 
tissue, the immune system faces several challenges. First, it must sense a pathogen and 
then deliver an appropriate adaptive immune response (Palucka and Banchereau, 2002).
The adaptive immune response is associated with the activation of effector cells, B and T 
lymphocytes, that are capable of specific recognition of microbial antigens, and is 
accompanied by the generation of memory cells that prevent infection with the same 
pathogen in future. Together, the innate and adaptive immune systems form an integrated 
host defence machinery to confer optimal protection (Moll, 2003).
22
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1.1.2. Immune recognition of bacteria:
Within the bacteria, there are four groups of especially significant human pathogens; these 
are Gram-negative and Gram-positive bacteria, mycobacteria and spirochaetes (Aderem 
and Ulevitch, 2000). A wide variety of bacterial components are capable of stimulating 
immune responses. After engagement of a pathogen with the epithelial surface and other 
components of the innate immune system such as DCs and macrophages, signals are 
generated that result in the production of chemokines and cytokines (Basset et al., 2003; 
Philpott et al., 2001). The basic feature of this activation of the innate immune system is 
pattern recognition (Janeway, Jr. and Medzhitov, 2002).
Pathogens are identified by the immune system by specific arrangements of key 
molecules called pathogen-associated molecular patterns (PAMPs) which are recognised 
by pattern recognition receptors (PRRs) (Table 1). The PAMPs are vital structures of the 
microbial cell such as lipopolysaccharide (LPS), peptidoglycan (PG), and 
oligosaccharides. The PRRs are found on many cells of the innate immune system (cell- 
associated receptors) including epithelial cells, macrophage-monocytes, granulocytes, 
mast cells and DCs. There are several different families of PRRs such as Toll-like 
receptors (TLR), scavenger receptors, mannose receptors, complement receptors (CR3) 
and CD 14. There are also several soluble receptors, which bind PAMPs, such as CD 14 
(also found associated with cells), lipopolysaccharide-binding protein (LBP) and the 
mannose-binding lectin (MBL) (Basset et al., 2003; Janeway, Jr. and Medzhitov, 2002). 
The main functions of PRR include opsonization, activation of complement cascades, 
phagocytosis, activation of proinflammatory signaling pathways, and induction of 
apoptosis (Janeway, Jr. and Medzhitov, 2002).
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Table 1-1: Bacterial PAMPs and pattern recognition receptors
PAMP Pathogen(s) PRR
LPS Most Gram negative bacteria LBP, CD 14 
TLR4, TLR2 
Scavenger receptor
Lipoproteins Eubacteria TLR2
Peptidoglycan Most Gram positive bacteria TLR2 
NOD 1/2
Lipotechoic acid Many Gram positive bacteria TLR2
Flagellin Bacteria TLR5
Mannans and Yeast Mannose receptor
mannoproteins
Mannose-binding protein
CpG DNA Bacteria TLR9
Lipoarabinomannan Mycobacteria TLR2
CD1
(Aderem and Ulevitch, 2000; Janeway, Jr. and Medzhitov, 2002; Philpott and Girardin, 
2004)
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1.1.3. Receptors involved in bacterial recognition
1.1.3.1. Toll-like receptors (TLR)
The Toll-like receptors are a set of conserved proteins that have been found in plants, 
insects and mammals (Underhill and Ozinsky, 2002). In humans, there are 10 TLRs with 
differing ligand-binding specificities (Takeda et al., 2003). TLRs are found on a wide 
range of cells including immune cells such as mast cells, macrophages and DCs. TLR2 
interacts with peptidoglycan, lipopeptides and other products from Gram-positive 
bacteria, acid fast bacteria and fungi, whereas TLR4 recognizes LPS produced by most 
Gram-negative bacteria (Takeda et al., 2003). Further diversification in microbial 
recognition is provided by TLR5, which recognizes bacterial flagellin (Hayashi et al., 
2001), and by TLR3, which recognizes double-stranded RNA produced during the course 
of many viral infections (Alexopoulou et al., 2001). Signaling pathways used by TLRs 
universally lead to activation of the transcription factor NF-kB and mitogen-activation 
protein kinases, general production of cytokines such as interleukin (IL)-6, IL-10 and 
IL-12, and expression of co-stimulatory molecules including CD40 and CD86 (Takeda et 
al., 2003).
1.1.3.2. Scavenger receptors
Scavenger receptors (SR) (e.g. SR-AI, SR-AII and MARCO [M0 receptor with a 
collagenous structure]) are expressed by myeloid cells (macrophages and DCs) and 
certain endothelial cells (Peiser et al., 2002). They bind and internalise bacteria and their 
products, including Gram-positive bacteria (lipoteichoic acid), Gram-negative bacteria 
(LPS), and are involved in clearing tissue sites of invading organisms by acting as 
receptors for phagocytosis (Basset et al., 2003).
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1.1.3.3. The mannose receptor family
The mannose receptor family is a subgroup of the C-type lectin superfamily (Weis et al., 
1998) and comprises four members; the mannose receptor (MR), the M-type 
phospholipase A2 receptor (PLA2R), DEC-205 and Endol80. The C-type lectin 
superfamily is a large group of transmembrane receptor and soluble proteins including the 
selectins, asialoglycoprotein receptor and collectins (East and Isacke, 2002). A 
characteristic feature of this family is that they all have the ability to be rapidly 
internalised from the plasma membrane via clathrin-coated vesicles for delivery into the 
endosomal system. MR receptor has been demonstrated to bind a wide variety of bacteria 
such as Mycobacterium tuberculosis and Klebsiella pneumoniae (East and Isacke, 2002).
DC-specific intercellular adhesion molecule (ICAM) grabbing non-integrin (DC-SIGN; 
CD209) is another type of C-type lectin specifically expressed by DCs and has two 
functions. Firstly, as an adhesion receptor, DC-SIGN supports initial DC/T cell interaction 
by binding to ICAM-3 (Geijtenbeek et al., 2000). Secondly, as a pathogen-recognition 
receptor, DC-SIGN was also shown to bind microorganisms such as Leishmania 
(Colmenares et al., 2002), and Mycobacterium (Geijtenbeek et al., 2003).
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1.13.4. Soluble receptors
Mannan-binding lectin (MBL), C-reactive protein (CRP), and serum amyloid protein 
(SAP) are secreted pattern recognition molecules produced by the liver during the acute 
phase response at the early stages of infection (Schwalbe et al., 1992; Gewurz et al., 
1982). CRP and SAP are members of the pentraxin family, and both can function as 
opsonins upon binding to phosphorylcholine on bacterial surfaces (Schwalbe et al., 1992; 
Gewurz et al., 1982). CRP and SAP can also bind to Clq and thus activate the classical 
complement pathway (Agrawal et al., 2001). MBL is a member of the collectin family 
that binds specifically to terminal mannose residues, which are abundant on the surface of 
many microorganisms (Janeway, Jr. and Medzhitov, 2002).
Another group of proteins involved in intercellular pattern recognition is the family of 
NOD (nucleotide-binding oligomerization domains) proteins. NODI and NOD2 have one 
and two caspase-recruitment domains (CARDs), respectively, as N-terminal effector 
domains (Philpott and Girardin, 2004). Both NODs acts as a bacterial peptidoglycan 
recognition molecule through specific detection of the conserved muramyl dipeptide 
structure (Girardin et al., 2003; Philpott and Girardin, 2004).
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1.2. Role of dendritic cells in bacterial infection
1.2.1. DC physiology
Secondary lymphoid organs provide the specialized microenvironment required for 
generating a specific immune response. Initiating immunity to a microbe that invades 
peripheral tissues thus requires linking of the infected peripheral site with secondary 
lymphoid organs. The dendritic cell is a crucial link between these two sites (Wick, 2002). 
They exist in distinct stages depending on their location and signals in their immediate 
environment, and have the capacity to migrate. The DC is also the most efficient type of 
APC that stimulates naive T cells. It is these unique properties of DCs that give them a 
central role in initiating and modulating immune responses (Banchereau and Steinman, 
1998).
DCs are produced from haematopoietic stem cells within the bone marrow and can be 
divided into subsets according to surface marker expression, specialized functions and 
tissue distribution (Liu, 2001). Immature DCs are found in blood, lymphoid and non­
lymphoid tissues where they perform a sentinel function for incoming pathogen, whereas 
mature DCs are primarily found in lymphoid tissues. In humans, two types of DC have 
been described: myeloid (C D llc+) and plasmacytoid (C D lie ) DCs. Myeloid DCs 
include epidermal DCs [also called Langerhans cells (LCs)] and dermal or interstitial 
DCs, which can also be found in other peripheral tissues (Liu, 2001). Additionally, 
immature myeloid DCs can be found in circulating blood or can be generated from blood 
precursors during their transit in peripheral tissues; these precursors are monocytes and 
the precursors of plasmacytoid DCs (PDCs) (Liu, 2001). PDCs are also known as type I
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interferon-producing cells (IPCs) owing to their capacity to release type I interferons after 
viral challenge (Colonna et al., 2002).
Monocytes (CD 14+) can differentiate into cells displaying features of immature DC or 
macrophages in response to GM-CSF and IL-4 or M-CSF, respectively (Sallusto and 
Lanzavecchia, 1994). However, monocyte differentiation is reversible and immature 
monocyte-derived DC or macrophages can interconvert into one another until late stages 
of their differentiation/maturation process (Palucka et al., 1998).
1.2.2. Interaction of DCs with bacteria
1.2.2.1. DCs as microbial sensors
When a microbe infects a tissue, resident immature DCs sense the microbe by recognizing 
evolutionarily conserved molecular patterns that are integral to microbial carbohydrates, 
lipids, and nucleic acids (or PAMPs). This is achieved through PRRs such as TLRs and 
MRs (Janeway, Jr. and Medzhitov, 2002). Mammalian TLRs have broad specificity for 
conserved molecular patterns shared by large groups of pathogens [such as LPS in Gram- 
negative bacteria and bacterial CpG DNA]. It appears that TLRs offer DCs a means of 
discriminating between different bacterial stimuli. Thus, Escherichia coli LPS signals 
through TLR4; peptidoglycans from Staphylococcus aureus and zymosan signal through 
TLR2; CpG bacterial DNA signals through TLR9; and bacterial flagellin signals through 
TLR5 (Alexopoulou et al., 2001; Hayashi et al., 2001; Takeda et al., 2003).
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1.2.2.2. Activation o f DCs by microbial products
Once a DC has detected a specific microbe, information about the pathogen is then 
relayed to naive T lymphocytes in the draining lymph nodes, in a sequence of events. 
First, immature DCs (imDCs) capture the microbe or its products by several mechanisms, 
including the actin-dependent process of phagocytosis (for particulate antigens) and 
receptor-mediated endocytosis or macropinocytosis (for soluble antigens) (Banchereau 
and Steinman, 1998). Then immature DCs exit the site of infection and migrate toward the 
T cell areas of the proximal lymph nodes via afferent lymphatics. During this journey, 
DCs differentiate into mature DCs (mDCs), losing their antigen-capturing capacities but 
acquiring the capacity to process and display peptide antigens on their surface, in 
conjunction with molecules of the major histocompatibility complex (MHC) (Table 2) 
(Banchereau and Steinman, 1998). To generate CD8+ cytotoxic killer cells, DC have to 
present antigenic peptides in the context of MHC class I molecules (Watts, 1997). Besides 
the classical presentation of processed antigen in the context of MHC class I and class II, 
DC can also employ the CD1 (hallmark of the DC phenotype) pathway to present 
microbial lipid containing antigen and induce an immune response to infectious agents, 
particularly Mycobacteria (Palucka and Banchereau, 1999).
For productive immunity to occur, DCs must present not only peptide-MHC complexes 
but also additional costimulatory signals (such as molecules CD80 and CD86) to T cells. 
The interaction between CD86 and its corresponding ligand CD28 on T cells results in the 
up-regulation of CD40 ligand on T cells. The T cells may then engage CD40 on DCs and 
trigger a burst of cytokine expression, including IL-12, which induces IFN-y in T cells 
(Banchereau and Steinman, 1998). Signaling through CD40 also up-regulates numerous 
other costimulatory molecules, which may play distinctive roles in tuning the immune 
response (Banchereau and Steinman, 1998; Pulendran et al., 2001).
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Table 1-2: Activation of DC function by microbial stimuli
Migration
Exit of active DCs from peripheral tissues 
Entry into T cell areas of secondary lymphoid tissues 
Antigen presentation
Antigen presenting molecule upregulation (MHCI, II and CD1) 
Formation of MHCII and peptides complexes 
Upregulation of T cell interaction molecules 
Costimulatory molecules [CD80, CD86]
Adhesion molecules (ICAM-1)
Signaling molecules (CD40)
Cytokine production
Induction of IL-2, TNF, IL-10, IL-6, IFN-cx/p 
(Reis e Sousa et al., 1999)
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1.2.2.3. Antigen presentation and T cell activation
The ability to prime naive T cells constitutes a unique and critical function of DC. 
Following antigen uptake DC migrate to the lymph nodes and, meanwhile, mature from 
Ag-capturing cells to become Ag-presenting/activating cells (Banchereau and Steinman, 
1998). In vitro, DCs induce the mixed leukocyte reaction (MLR), where only one DC is 
necessary to activate 100-3000 T cells. The high efficiency of T cell activation may be 
due to the persistent expression of high levels of antigens and costimulatory molecules. 
For example, MHC-peptide complexes are 10-100 times higher on DC than on other APC 
like B cells and monocytes. Recognition of MHC/peptide complexes on DC by antigen- 
specific T cell receptor (TCR) constitutes the "first signal" in DC-T cell interaction 
(Banchereau and Steinman, 1998). This initial step is strengthened by high expression of 
several adhesion molecules, like integrins B1 and B2 and members of the 
immunoglobulin superfamily (CD2, CD50/ICAM-3, CD54/ICAM-1, and CD58/LFA-3). 
Several accessory molecules, expressed on DC (CD80, CD86, CD40), interact with 
ligands and counter-receptors on T cells, constituting the "second signal", which is 
required to sustain T cell activation (Palucka and Banchereau, 1999; Banchereau and 
Steinman, 1998).
Activated CD4+ T lymphocytes can differentiate into either T helper 1 (Thl) or T helper 2 
(Th2) cells that secrete specific types of cytokines. In general, Thl cells secrete the 
cytokines IFN-y and TNF-a, and are associated with a strong cell-mediated response, 
whereas Th2 lymphocytes secrete the cytokines IL-4, IL-5, IL-10, and IL-13, and are 
characterized by a humoral or antibody-mediated immune response (Lucey et al., 1996).
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The activation of the Thl immune response is dependent on IL-12, which is secreted by 
macrophages and DC (O'Garra et al., 1995).
1.2.3. Bacterial evasion of DC function
Infectious agents evolved and established a multitude of strategies to interfere with the 
development of host immunity at several levels (Moll, 2003). As dendritic cells have a 
key function in initiating and connecting both arms of the immune responses, the 
suppression of dendritic cell maturation, migration and antigen presentation as well as the 
inhibition of dendritic cell-mediated T cell activation provide means to facilitate the 
survival of microbial pathogens inside the hosts (Palucka and Banchereau, 2002; Moll, 
2003). Several recent studies have documented the modulation or impairment of DC 
functions by bacteria including Salmonella, Mycobacteria, Streptococcus, Neisseria and 
Helicobater, or bacterial toxins such as anthrax lethal and E. coli heat labile toxins.
1.2.3.1. Interference with DC generation and survival
Pathogens can affect DC migration to the infected tissues, their differentiation and their 
survival (Palucka and Banchereau, 2002). Induction of DC apoptosis by phagocytosed 
bacteria may be regarded as a microbial strategy to evade the immune system. However, 
this mechanism could be an effective host action to limit intracellular bacterial replication 
(Colino and Snapper, 2003). The ability of Helicobacter pylori to induce apoptosis in 
human monocytes suggests that this may be an important strategy for the evasion of 
immune recognition through a reduction in the number of imDC (Galgani et al., 2004). 
Furthermore, bacteria can affect DC viability, in particular, Salmonella typhimurium (van
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der Velden et al., 2003) and Streptococcus pneumoniae (Colino and Snapper, 2003) can 
rapidly kill DC by induction of apoptosis.
1.2.3.2. Interference with antigen-presentation functions
Microbes have developed several means to interfere with the ability of DCs to present 
antigens to T cells preventing the induction of specific immune responses. For instance, 
microbes can prevent DC maturation either directly or indirectly and this inhibition has 
two beneficial consequences for microbes, on the one hand, prevention of microbe- 
specific immunity and on the other, induction of microbe-specific tolerance, when 
immature DCs present microbial antigens in the absence of costimulatory signals (Palucka 
and Banchereau, 2002).
Kikuchi et al (2004) demonstrated that the Gram-negative bacillus, Legionella 
pneumophila, has the ability to impair DCs maturation (Kikuchi et al., 2004). In addition, 
Bordetellae bronchiseptica can alter DC function by affecting DC signalling pathways 
that control DC maturation, leading to increased bacterial survival within the host 
(Skinner et al., 2004). Furthermore, the expression of serotype B polysaccharide by 
Neisseria meningitides inhibited adherence to DCs (Kolb-Maurer et al., 2001). Thus, 
impairment of DC maturation by encapsulated variants may help the bacterium to escape 
from host immune defence mechanism (Colino and Snapper, 2003). Several bacterial 
toxins have recently been reported to alter DC function and therefore impair the protective 
immune response against the bacteria. Anthrax lethal toxin (Agrawal et al., 2003) as well 
as Escherichia coli heat-labile enterotoxin (Petrovska et al., 2003) have been shown to 
impair DC function and induce an adaptive immune response.
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1.2.3.3. Interference with T cell activation
Microbial pathogens can modulate cytokine release by DCs (Tortorella et al., 2000). The 
production of IL-12 by dendritic cells in the early phase of an adaptive immune response 
is essential for the development of Thl cells that mediate host resistance to pathogens 
(Moll, 2003). Autocrine IL-10 has been shown to down regulate the IL-12 response of 
dendritic cells after mycobacterial infection, as mannosylated lipoarabinomannans from 
M. bovis and M. tuberculosis are able to inhibit IL-12 production by DCs (Demangel et 
al., 2002; Nigou et al., 2001). Dendritic cells exposed to Bordetella pertussis filamentous 
hemagglutinin are also impaired in their ability to produce IL-12, but release IL-10 and 
induce antigen-specific regulatory T cells that suppress protective Thl responses 
(McGuirk et al., 2002).
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1.3. Staphylococcus aureus
1.3.1. Bacteriology
The genus Staphylococcus belongs to the family Micrococcaceae. The organisms are 
Gram-positive cocci, about 1 pm in diameter, and occur in an irregular grape-like cluster. 
They are catalase-positive and oxidase-negative. S. aureus is a non-motile, non-spore- 
forming, facultative anaerobe that can grow in medium containing 15% sodium chloride 
and at the temperature range of 15°C to 45°C. S. aureus is distinguished from the 
remaining staphylococcal species on the basis of the golden pigment of colonies on rich 
medium and it is positive for coagulase, deoxyribonuclease and mannitol-fermentation 
(Gillespie, 1994; Murray et al., 1994).
The staphylococcal cell wall (Fig 1-1) has a thick peptidoglycan layer surrounding the 
cytoplasmic membrane of the cell. Peptidoglycan consists of alternating polysaccharide 
subunits of A-acetylglucosamine and A-acetylmuramic acid. Another important 
component of the cell wall is lipoteichonic acid (LTA). LTA is a glycerol phosphate 
polymer linked to a glycolipid terminus anchored in the cytoplasmic membrane (Lowy, 
1998). These components have endotoxin-like activity, stimulating the release of 
cytokines by macrophages and DC (IL-1(3, IL-6, IL-8, and TNF), activating the alternative 
complement pathway, and aggregation of platelets. (Lowy, 1998; Nair et al., 2000) 
Peptidoglycan and LTA induce DC maturation via TLR2 (Michelsen et al., 2001).
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Figure 1-1. Staphylococcus aureus structure
(A) The synthesis of many of surface and secreted proteins is dependent on the growth 
phase. (B and C) Cross sections of the cell envelope, many of the surface proteins have a 
structural organization similar to that of clumping factor. Adapted from (Lowy, 1998)
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Most strains of S. aureus (90%) produce capsular polysaccharide, which forms an outer 
surface layer on the peptidoglycan in the cell wall. There are 11 different capsular 
serotypes that can be produced by S. aureus, serotypes 5 and 8 are the most common, 
occurring in 80% of strain isolated from human infections (Lowy, 1998). It has been 
reported that capsular polysaccharide can enhance staphylococcal virulence by inhibiting 
phagocytosis (Lowy, 1998; Nair et al., 2000).
Protein A is a surface protein of S. aureus that has the ability to help evade the host 
immune system by binding to the Fc portion of immunoglobulin (IgG). Bacteria will bind 
IgG molecules in the wrong orientation on their surface and there by disrupt opsonization 
and phagocytosis (Lowy, 1998; Nair et al., 2000).
Coagulase is an extracellular protein that exists in free and bound forms. It binds to 
prothrombin in a 1:1 ratio forming a complex called staphylothrombin. The binding 
reaction catalyses plasma clotting. This clot may provide protection to the bacterium, 
which may be coated with fibrin and it inhibits phagocytosis. Coagulase is a traditional 
marker for identifying S. aureus in clinical microbiology (McDevitt et al., 1992; Nair et 
al., 2000).
S', aureus also produces a group of surface proteins that promote attachment to host 
extracellular matrixs as an initial step in the colonization process These proteins are 
collectively known as microbial surface components recognizing adhesive matrix 
molecules (MSCRAMM) (Foster and Hook, 1998). Most of MSCRAMMs are anchored 
in the cell wall peptidoglycan and have the ability to bind to a variety of host matrix
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proteins such as fibronectin, collagen, fibrinogen and elastin (Lowy, 1998; Nair et al., 
2000).
The genome of S. aureus consists of a circular chromosome (of about 2800bp), with 
prophages, plasmids, and transposons. Genes involved in virulence and resistance to 
antibiotics are found on the chromosome and on extra-chromosomal elements (Lowy, 
1998). S. aureus virulence factor production is growth phase-dependent in liquid culture, 
most exotoxins are produced in the post-exponential phase of growth and are not required 
for growth and multiplication of the bacterium. The regulation of virulence factor 
production in S. aureus is controlled by at least two global regulators, agr (Accessory 
Gene Regulator) and sar (Staphylococcal Accessory Regulator) (Yarwood et al., 2001).
1.3.2. Staphylococcus aureus infections
The organisms normally grow on the skin and/or mucous membranes in 20-50% of the 
population. These barriers prevent the organisms from gaining access to other body 
organs and tissues (Nair et al., 2000). Human staphylococcal infections are frequent, but 
usually remain localized at the portal of entry by the normal host defenses. The portals of 
entry are usually a break in the skin by needle-stick or surgical wound and the respiratory 
tract. The localized host response to infection is inflammation, swelling, the accumulation 
of pus, and necrosis of the tissue (Gillespie, 1994). S. aureus is responsible for a number 
of human diseases such as those affecting the skin: impetigo, pustules, boils, carbuncles, 
and cellulitis. It is also a common cause of postoperative sepsis, wound infection, 
abscesses, pyogenic infection (e.g. endocarditis and osteomyelitis), septicaemia, food 
poisoning and toxic shock syndrome (Dinges et al., 2000; Bergdoll, 1989).
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S. aureus causes disease by producing a large numbers of exoproteins or virulence factors 
(Murray et al., 1994; Bergdoll, 1989). There are two types of exoproteins: (a) enzymatic 
proteins that may help to provide nutrients for bacteria, such as nucleases, hyaluronidase, 
proteases, collagenases and lipases; (b) exotoxic proteins that are the causative agents of 
disease, including toxic shock syndrome toxin-1 (TSST-1), staphylococcal enterotoxins 
(SEs), exofolative toxin (ETs), and Panton-Valentine leukocidins (Proft and Fraser, 2003; 
Bergdoll, 1989). Some exoproteins, for instance the hemolysins (a, p, y, and 8) possess 
both enzymatic and toxin activities (Murray et al., 1994).
1.3.3. Pyrogenic exotoxin as superantigens
1.3.3.1. Super antigens: definition and mechanism o f immune stimulation
White et al (1989) (White et al., 1989) described a group of microbial antigens that are 
able to activate a large fraction (5-20%) of the resting T-lymphocyte population, 
compared to the small numbers (one in 10M06 T-cells) activated with conventional 
proteins or peptide antigens. These were termed superantigens (SAgs) (Table 3). T- 
lymphocytes can recognize a wide variety of antigens via highly diverse cell-surface 
glycoproteins known as T cell receptors (TCR). These disulfide-linked heterodimers are 
composed of a  and p or y and 8 chains that have variable (V) and constant (C) regions 
that are very similar in structure of the Fab (antigen binding) fragment of an 
immunoglobulin molecule. Unlike antibodies, which recognize antigen alone, TCRs 
recognize antigen only in the form of peptide bound to major histocompatibility complex 
(MHC) molecules (Henderson et al., 1999; Proft and Fraser, 2003).
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Table 1-3: Comparison of antigen, superantigen, and mitogen
Feature Antigen Superantigens Mitogen
Percentage of stimulated cells 0.0001-0.000001 5-20 80-90
Accessory cell requirement s
Dependence on MHC-II 
expression
s X
Antigen processing s X X
Restricted T cell V(3 usage by 
stimulating cells
S/ (X) X
(Kotb, 1995; Henderson et al., 1999)
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Normally, antigen presenting cells (APC) break down antigens into small peptides, which 
form complexes with MHC class II molecules. These complexes are transported to the 
cell surface (MHC peptide-binding groove) to bind with ap-TCR (Kotb, 1995). SAgs 
bind to MHC class-II on APCs (B-cells, monocytes, and dendritic cells) and are 
recognized by TCRs, but in a different way than MHC class-II-antigen complexes are 
recognized. The main characteristic of superantigens is that they do not need processing 
by the APCs and they can activate T-cells by binding with the variable region of the P 
chain of TCR (VP) (Henderson et al., 1999; Proft and Fraser, 2003; Marrack and Kappler, 
1990).
The cross-linking between T-cells and SAgs does not always lead to activation and 
proliferation of T-cells, but responding cells can either enter a state of unresponsiveness 
termed T-cell anergy, or in the presence of high level of tumor necrosis factor-a (TNF-a), 
and interferon-y (IFN-y) they become apoptotic (Henderson et al., 1999; Kotb, 1995; Proft 
and Fraser, 2003). SAg binding induces both the APC and T lymphocyte to produce a 
variety of cytokines including, interleukins-1 (IL-1), TNF-a, IL-2, TNF-p and IFN-y 
(Fig 1-2). This dramatic activation causes toxic shock syndrome (Le Loir et al., 2003).
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Figure 1-2: Schematic diagram showing the superantigen (SAg) interaction with 
MHC class n  and TCR.
The processed antigen (Ag) peptide presented by MHC class II which binds specific T 
cell bearing antigen specific TCR. In contrast, SAg binds directly to the MHC molecule 
outside the antigen binding site and cross-links it to the VP chain, which initiates non­
specific activation of T cells and induces massive production of cytokines.
43
Chapter 1 General Introduction
1.3.3.2. Staphylococcus aureus superantigens
The known staphylococcal pyrogenic superantigens are the staphylococcal enterotoxins 
(SEs) and toxic shock syndrome toxin-1 (TSST-1) (Kotb, 1995; Proft and Fraser, 2003). 
SAgs secreted by S. aureus are globular proteins of 22-29 KDa (Table 4) that are resistant 
to proteases and heat denaturation and are able to be absorbed by the epithelium as 
immunologically intact proteins (Hamad et al., 1997).
SAgs have the following characteristics, (a) they are among the most potent pyrogens 
known, (b) they are capable of inducing lethal toxic shock syndrome, and (c) they share a 
typical three-dimensional structure consisting of two domains termed large and small. The 
small domain, domain B, is a p-barrel made up of two p-sheets, whereas the large 
domain, domain A, contains a p-grasp motif and an a-helix packed against a mixed p- 
sheet that connects the peripheral strands (Li et al., 1999; Prasad et al., 1993; Proft and 
Fraser, 2003; Swaminathan et al., 1992).
The level of sequence homology between the staphylococcal SAgs varies widely, and 
they can be divided into groups based on sequence similarities. SEA, SED and SEE 
would fall into one group (53-81%) and SEB and SECs (50-66%) would fall into another. 
All the rest, including TSST-1, have poor or no homology to another toxin (Kotb, 1995; 
Li et al., 1999; Proft and Fraser, 2003).
44
Chapter 1 General Introduction
The interaction of SAgs with MHC class II molecules appears to involved more than one 
bind site and varies among these toxins (Proft and Fraser, 2003). Both SEB and TSST-1 
have a hydrophobic loop region in the smaller N-terminal domain which binds to a 
hydrophobic groove of HLA-DR (Prasad et al., 1993; Swaminathan et al., 1992). 
However, the structures of these toxins are not identical. SEB binds out to the side of the 
MHC II peptide binding groove while TSST-1 sits over the top of the groove and makes 
contacts with the peptide residues. According to this feature, TSST-1 prevents any contact 
between MHC II and the TCR while SEB relies on continued contacts between MHC and 
TCR to strengthen the interaction (Li et al., 1999; Papageorgiou et al., 1995; Proft and 
Fraser, 2003). The affinity of SAgs towards MHC class II also varies. SEB and TSST-1, 
bind with relatively low affinity, while other SAgs, such as SEA and SEE, have high- 
affinity zinc-mediated binding site for the polymorphic HLA-DR (Dinges et al., 2000; 
Kotb, 1995; Le Loir et al., 2003; Proft and Fraser, 2003).
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Table 1-4: Staphylococcus aureus superantigens
Toxin Molecular mass (KDa)
SEA 27.1
SEB 28.4
SEC1 27.5
SEC2 27.6
SEC3 27.6
SED 26.9
SEE 26.8
SEG 27.0
SEH 25.2
SEI 24.9
SEJ 28.5
SEK 25.3
SEL 24.7
SEM 24.8
SEN 26.1
SEO 26.7
SEP 26.4
SEQ 26.0
TSST-1 21.9
(Lina et al., 2004; Proft and Fraser, 2003)
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1.3.3.2.1. Staphylococcal Enterotoxins (SEs):
These proteins are heat stable exotoxins that are known for causing one of the common 
food-borne illnesses, food poisoning (intoxication), associated with ingestion of toxin- 
contaminated food (Orwin et al., 2001). This contamination is usually linked to poor 
hygiene and improper storage of food (Bean et al., 1996). Most cases are self-limiting 
after 24 hours of ingestion. In the first 4 hours patients may have diarrhea, nausea, 
vomiting and abdominal pain or cramping. Eighteen staphylococcal enterotoxins have 
been described in the literature, which share structure and sequence similarities (Table 4) 
(Lina et al., 2004; Proft and Fraser, 2003; Orwin et al., 2003).
Enterotoxin activity is uniquely characterized by the ability to cause an emetic response 
when administered orally to humans and primates, whilst other superantigens are not 
emetic (Dinges et al., 2000). The infective dose required to induce staphylococcal food 
poisoning in human is approximately 0.1 pg, and it depends on patient sensitivity 
(Evenson et al., 1988). Although there are many reports on the structure-function 
relationship of superantigen activity of SEs, the emetic activity has not been fully 
documented. One common structural characteristic of SEs is a cystine loop, suggested to 
be involved in emetic activity (Dinges et al., 2000). However, SEI lacks that loop 
structure and has both emetic and superantigenic activities (Munson et al., 1998). SEK 
and SEL are recently identified superantigens in which the cystine loop is missing 
(Fitzgerald et al., 2001; Orwin et al., 2003). These later SEs have not been tested for their 
emetic activity yet (Le Loir et al., 2003).
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1.3.3.2.2. Toxic Shock Syndrome Toxin-1 (TSST-1):
Toxic shock syndrome (TSS) is a disease caused by Staphylococcus aureus and 
characterized by fever, rash, hypotension and multiple organ failure. TSS cases are 
associated with strains of S. aureus that produce TSST-1 (Murray et al., 1994; Proft and 
Fraser, 2003). TSST-1 is a potent superantigen that interacts with human T-cells via Vp2 
elements (Dinges et al., 2000), and induces the production of excessive amounts of 
inflammatory cytokines (Dinges et al., 2000; Kotb, 1995).
1.3.4. Staphylococcal Superantigen-Like proteins (SSL):
Staphylococcal superantigen-like (SSL) proteins (previously staphylococcal exotoxin-like 
proteins (SET)) are a group of proteins produced by S. aureus that contain SAg signature 
sequences. They were first identified as a genetic locus encoding at least five exotoxin­
like proteins (SET1-5), and were reported to have the capability to stimulate the secretion 
of some proinflammatory cytokines, such as IL-lp, IL-6 and TNF-a, by human peripheral 
blood mononuclear cells (PBMCs) (Williams et al., 2000). More recently, the whole 
genome sequence of different S. aureus strains has revealed a large number of related (36- 
67%) set genes on the SaPIn2 pathogenicity island of S. aureus genome (Baba et al., 
2002; Kuroda et al., 2001). There appears to be extensive inter-strain allelic 
polymorphism for each of the set genes (Baba et al., 2002; Fitzgerald et al., 2003; Kuroda 
etal., 2001) (Fig 1-3 and 1-4).
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It has recently been reported, that members of this family of proteins do not have the main 
properties of superantigens, such as superantigenicity, pyrogenicity, and enhancement of 
endotoxin shock (Arcus et al., 2002; Fitzgerald et al., 2003). Arcus and colleagues (Arcus 
et al., 2002) determined the first three-dimensional structure of a protein, SET3, belonging 
to this family. The crystal structure of this protein shows the characteristic structure of the 
superantigen super-family, however, this protein family may have a non-redundant 
biological function that is completely different from that of the superantigens.
The International Nomenclature Committee for Staphylococcal Superantigen 
Nomenclature (INCSS) has recently recommended that the SETs be renamed 
staphylococcal superantigen-like proteins (SSLs) and should be named ssl 1 to ssl 11 in 
clockwise order from the replication origin of the chromosome based on homology to the 
full complement of genes found in strain MW2 (Lina et al., 2004). This nomenclature is 
essentially as described by Fitzgerald et al (Fitzgerald et al., 2003) except that the 
numbering of the genes is in the opposite direction (Fig 1-3). To differentiate between 
allelic variants the ssl gene is prefixed by the strain name. This nomenclature is used 
throughout this thesis.
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Figure 1-3. The SET proteins encoded by the genes designated as setl to setll; in 
eight S. aureus strains.
Comparison of chromosomal regions from different S. aureus strains; 8325, Sanger 
MSSA, MW2, Sanger MRSA, N315, Mu50, COL, and NCTC6571, indicates that the set 
genes in different strains are allelic variants of each other. The SETs were renamed 
staphylococcal superantigen-like exoproteins (SSLs) using the numbering system SET(x) 
introduced by Fitzgerald et al (Fitzgerald et al., 2003); but ssl 1 to ssl 11 in clockwise order 
from the replication origin of the chromosome based on homology to the frill complement 
of genes found in strain MW2 (Lina et al., 2004). Adapted from (Fitzgerald et al., 2003).
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Figure 1-4: Phylogenetic tree showing the relationship between the members of 
SSL (SET) family.
The SETs renam ed staphylococcal superantigen-like exoproteins (SSLs) using the numbering 
system  SET(x) introduced by Fitzgerald et al (Fitzgerald et al., 2003) but in the opposite direction.
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1.4. Aim and objectives of thesis
The aim of this thesis is determination and understanding of the immunological functions 
of the SSL protein family. The investigation will be divided into three main objectives; 
each will be discussed in a separate chapter:
1. Characterisation of the interaction between SSL proteins and cells of the immune 
system; the cell populations which bind to these proteins and the features of this 
binding will be investigated.
2. The influence of SSL proteins on DC functions such as endocytosis and antigen 
presentation, as well as the immunological responses toward these secreted 
proteins in the normal human population will be assessed.
3. Biochemical methods will be used to identify the SSL receptor(s) from selected 
cell lines.
52
Chanter 2 Materials & Methods
CHAPTER II
Material and Methods
53
Chapter 2 Materials & Methods
2. Materials & Methods
2.1 Molecular biology
2.1.1 Cloning and purification of recombinant proteins
2.1.1.1 Cloning o f  ssls and embp32 genes into the pQE30 vector
The ssls genes (ssl4, ssl5, ssl7, ssl9 and ssl 10) from S. aureus NCTC 6571 and embp32 
gene from S. epidermidis NCTC 11047 were cloned into pQE30 (Qiagen Ltd) an N- 
terminal histidine tag fusion vector and introduced into E. coli M607 (pREP4), by Dr. 
Rachel Williams, Division of Microbial Diseases, Eastman Dental Institute, UCL. 
Investigations into the conditions for optimal expression of rSSL proteins revealed that 
SSL7 and SSL9 were expressed in highest amounts, and these two proteins were therefore 
chosen for further study.
2.1.1.2 Expression and purification o f recombinant proteins
Clones were grown overnight at 30°C with shaking in 20 ml Luria-Bertani (LB) broth 
containing 100 pg/ml ampicillin and 25 pg/ml kanamycin. The overnight cultures were 
used to inoculate 200 ml of fresh medium and incubated at 37°C for 2 hours. Gene 
expression was induced with 200 pi of 1M isopropyl-B-D-thiogalactopyranside (IPTG) 
for 4 hours at 30°C. Cells were harvested by centrifugation at 6,000 X g  at 4°C for 20 
minutes in a Sorvall RC5B centrifuge, and stored at -20°C overnight.
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Cells were harvested and lysed for 30 minutes at 4°C in 4 ml B-PER (Bacterial Protein 
Extraction Reagent, Pierce & Warriner LTD.) containing 20 mM imidazol, 40 pi of 120 
mM PMSF (phenylmethyl-sulfonyl fluride) and 4 pi each of 1 mM E64, 10 mM leupeptin 
and 1 mM peptatin as protease inhibitors. The lysate was clarified by centrifugation at
23,000 X g  for 10 minutes. Recombinant proteins were purified using Ni-nitrilotriacetic 
acid-agarose columns (Ni-NTA, Qagen Ltd.). The columns were washed with B-PER and 
PBS containing 20 mM imidazol. 2.5 mg of polymixin B per ml in wash buffer was 
loaded onto the column to remove contamination with lipopolysaccharide (LPS). 
Recombinant proteins were eluted from the column with PBS containing 250 mM 
imidazole. Finally, rSSLs and rEmbp32 were subjected to dialysis using Slide-A-lyzer 
cassettes (Pierce) against PBS buffer to remove imidazol. All rSSL proteins were 
homogenous as determined by sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE) and migrated with molecular masses of between 23 to 
27kDa (Fig. 2-1)
2.1.2 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)
SDS-PAGE was performed using a Mini PROTEAN II electrophoresis tank (Bio-RAD). 
The separating gel (8cm x 7cm) was made with 0.4M Tris-HCl pH 8.8, 0.1% (w/v) SDS 
and 12% (w/v) acrylamide mix [29.2% (w/v) acrylamide, 0.8% (w/v) bisacrylamide; 
National Diagnostic, UK], 50pl of 10% ammonium persulphate (APS) and 5pl of 
TEMED (N,N,N',N’-tetramethylethylenediamine) per 5ml gel were added, to give 12% 
gel. 10% gels were performed in same way but by adding 10% acrylamide mix (w/v). 
Once poured into the gel apparatus, it was overlaid with distilled water to produce a flat 
surface to the gel and allowed to set for 45 minutes at room temperature.
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The stacking gel was then prepared and poured on top of the separating gel. This 5% gel 
was made with 0.125M Tris-HCl pH 6.8, 0.1% (w/v) SDS, 3.9% (w/v) acrylamide mix, 
and 50pl 10% APS and 5pi TEMED were added per 5ml gel. A comb was inserted after 
pouring the gel to allow wells to form for sample application. The gel was left to set for 
30 minutes at RT before the comb was removed and the gel mounted onto the 
electrophoresis apparatus. Samples were mixed with 5X reducing sample buffer (Pierce, 
UK) and boiled at 95°C for 5 minutes prior to loading on the gel. SDS-PAGE running 
buffer (25mM Tris-HCl pH 8.3, 250mM glycine, 0.1% SDS) was added to the apparatus. 
Samples and broad range molecular mass markers (New England Biolabs, UK) were 
electrophoresed through the stacking gel at constant current of 30 mA per gel. Once the 
samples had passed through the stacking gel the current was reduced to 15 mA per gel 
until the dye front reached the bottom of the gel.
2.1.2.1 Staining SDS-PA GE gels
Gels were first fixed for one hour with 40% (w/v) methanol, 15% (v/v) acetic acid at 
room temperature (RT). Colloidal Brilliant blue concentrate (Sigma) was made up 
according to manufacturer instruction and four parts of stain were mixed with one part of 
methanol immediately prior to use. The gels were soaked overnight in the stain before 
destaining in water
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Figure 2-1. Purification of SSL7 and SSL9 proteins by Ni-NTA affinity 
chromatography.
The ssls genes (ssl7 and ssl9) from S. aureus NCTC 6571 were cloned into pQE30 an N- 
terminal histidine tag fusion vector and introduced into E. coli M607 (pREP4). SSL7 and 
SSL9 proteins were expressed and purified using Ni-NTA columns. The columns were 
washed with B-PER and PBS containing 20 mM imidazol. Polymixin B was loaded onto 
the column to remove contamination with lipopolysaccharide (LPS). Recombinant 
proteins were eluted from the column with PBS containing 250 mM imidazole. The figure 
is a photograph of Colloidal Brilliant blue stained 12% SDS-PAGE. The lane and 
numbers on the left represent molecular mass standards in kilodaltons.
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2.1.3 Cloning of the ssl7 gene into the pGEX vector
In order to produce recombinant SSL7 protein without the histidine tag, a cleavable 
affinity tag was introduced. The NCTC6571 ssl7 gene from pQE30 was subcloned into 
the glutathione 5-transferase (GST) expression vector pGEX-4T-l on a BamHl-Sall 
fragment and transformed into E. coli JM109.
2.1.3.1 Plasmid DNA isolation
The plasmid pQE30 containing NCTC6571 ssl7 gene was purified from 10 ml of 
overnight culture using the Qiagen plasmid miniprep kit (Qiagen) according to the 
manufacturer’s instructions. Plasmid DNA was stored at -20°C.
2.1.3.2 Agarose gel electrophoresis
To make 1% (w/v) agarose gel, agarose powder was weighed out and dissolved in Tris- 
Borate EDTA (TBE) buffer (90mM Tris-HCl, 90mM boric acid, ImM EDTA) by heating 
in a microwave. After the solution had cooled to less that 50°C, ethidium bromide was 
added to a final concentration of 0.5pg/ml and the mixture poured into a horizontal 
casting tray. The tray also held a template comb to form loading wells. The gel was then 
left for 30 minutes to set at room temperature. The gel was placed in an electrophoresis 
tank (Biometra) containing TBE and the comb was removed gently. The samples to be 
analysed were mixed (5:1) with 6x gel loading buffer (0.25% bromophenol blue, 40% 
sucrose, 0.1M EDTA). Samples and markers (New England Biolabs) were loaded into the 
gel wells and electrophoresis was performed at 50V for 30-60 minutes. The plasmid DNA 
was visualised under UV light (365nm) and photographed using a multiimage™ Light
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Cabinet with Alphalmager™ 1220 documentation and analysis system (Alpha Innotech 
Corporation, UK)
2.1.3.3 Isolation o f  DNA from  agarose gels
DNA bands of interest were excised from the agarose gel using a sterile scalped blade, 
and the gel slices transferred to a sterile tube. The DNA was then isolated from the gel by 
using the Qiagen Gel Extraction Kit, according to the manufacturer’s instructions. DNA 
was stored at -20°C.
2.1.3.4 Restriction enzyme digestion
Digestion of plasmid pQE30 containing NCTC6571 ssl7 gene and pGEX-4T-l was 
carried out using BamWl and Sail restriction endonucleases. Plasmid was incubated with 1 
pi of restriction enzymes (6-12U) and 2 pi of the appropriate lOx buffer in a total volume 
of 20pl at 37°C for 4 hours.
2.1.3.5 Ligation o f  the ssl 7 gene to the pGEX-4 T-l vector
1 pg of restriction enzyme-digested plasmid and ssl7 gene were added to a tube with 2 pi 
of lOx ligation buffer and 5U of ligase enzyme (New England Biolabs). The mixture was 
made up to a final volume of 15 pi and incubated overnight at 4°C.
2.1.3.6 Preparation o f  competent cells
A single colony of E. coli JM 109 was used to inoculate 5ml of LB medium and incubated 
overnight at 37°C with shaking. The next day 60 pi of the overnight culture was used to 
inoculate 10 ml of fresh LB medium. The bacteria were grown at 37°C with shaking to 
reach an absorbance at 600nm of 0.5. The cells were then harvested by centrifugation at
4,000 X g for 15 minutes at 4°C in an Eppendorf 5804R centrifuge. Cells were
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resuspended in 5ml of ice cold 75mM CaCl2 , 15% glycerol. The cells were harvested by 
centrifugation at 4,000 x g for 15 minutes at 4°C. The supernatant was discarded and the 
cells were resuspended in 1 ml of ice cold 75mM CaCl2, 15% glycerol. The cells were 
divided into 150jnl aliquots and stored at -70°C immediately.
2.1.3.7 Transformation o f  competent E. coli
Ligation mix (10 pi) was added to competent E. coli JM109 cells suspension (150 pi), 
mixed and incubated for 45 minutes on ice. The cells were heat-shocked at 42°C for 30 
seconds, and returned to ice for an extra 2 minutes. LB broth (1 ml) was added to the cells 
and incubated for a further 1 hour at 37°C with shaking. Cell suspensions were 
centrifuged at 5000 rpm for 10 minutes, then 100 pi of LB medium were mixed with the 
pellet and plated overnight on LB agar containing 100 pg/ml ampicillin.
2.1.3.8 Western blotting
In order to check the conditions for optimal expression of rSSL7 protein, small scale 
cultures were prepared. Positive clones were cultured (10 ml) and induced with a range of 
concentrations of IPTG (0, 0.25 and 1M) at 30°C or 37°C and samples taken every 2 
hours after incubation. Cells were harvested and resuspended in 100 pi B-PER containing 
proteases inhibitors (Sigma). The supernatants were clarified by centrifugation at 5000 
rpm for 10 minutes and separated by 12% SDS-PAGE.
The gel was removed from the electrophoresis tank and soaked in blotting buffer (28.8g 
glycine, 6g Tris-HCl, 400ml methanol, made up to 2 litters with dH20 )  for 1 hour. 
Immobilon-P polyvinylidene fluoride (PVDF) membrane was then placed on top of the 
gel and sandwiched between eight pieces of blotting papers. The sandwich was placed 
into a Mini PROTEAN II electrophoresis tank submerged in blotting buffer. The tank was 
then subjected to a constant voltage of 15V for 16 hours. Membranes were removed from
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the tank and soaked in wash buffer (PBS containing 0.1% (v/v) Triton X-100) for 10 
minutes, then incubated in blocking buffer (PBS, 0.1% (v/v) Triton X-100, 5% (w/v) 
skimmed milk) for 1 hour. Afterward, the membranes were incubated with goat anti-GST 
antibodies (Amersham), diluted appropriately in blocking buffer, for 2 hours. The 
membranes were washed 5 times before being incubated with detection antibody, a 
horseradish peroxidase (HRP) conjugate (Sigma) diluted in blocking buffer, for 1 hour. 
The membranes were washed 5 times with wash buffer before developing with 
diaminobenzidine (DAB, Sigma) until the bands could be seen. The membranes were 
dried, photographed and stored in a dark place to prevent the bands from fading.
Once the best conditions for expression were established, larger cultures were induced to 
allow protein isolation.
2.1.3.9 Expression and purification o f rSSL 7 protein
For gene expression, an overnight culture was diluted 1:25 in fresh LB broth containing 
100 pg/ml ampicillin and incubated for 2 h at 37°C. Gene expression was induced with 1 
mM IPTG for 4 h at 37°C. Cells were harvested by centrifugation at 6,000 X g  for 30 min, 
resuspended, and lysed for 20 min in B-PER protein extraction reagent (Pierce & 
Warriner Ltd.) containing protease inhibitors (Sigma). Lysates were clarified by 
centrifugation at 23,000 X g  for 10 min. The lysate containing the GST-SSL7 fusion 
protein was passed through a HiTrap GST-Sepharose column (Amersham-Pharmacia 
Biotech), and recombinant SSL7 without the GST tag was released from the column by 
digestion with thrombin essentially as described by the supplier of the column 
(Amersham-Pharmacia Biotech). SSL7 protein was homogenous as determined by SDS- 
PAGE and migrated with molecular masses of about 24kDa (Fig. 2-2)
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Figure 2-2. Purification of SSL7 protein by GST affinity chromatography.
The NCTC6571 ssl7 gene from pQE30 was subcloned into the glutathione S-transferase 
(GST) expression vector pGEX-4T-l and was transformed into E. coli JM109. Gene 
expression was induced with 1 mM IPTG, cells then were harvested by centrifugation. 
The lysate containing the GST-SSL7 fusion protein (50 KDa) was passed through a GST- 
Sepharose column, and recombinant SSL7 without the GST tag was released from the 
column by digestion with thrombin. The figure is a photograph of Colloidal Brilliant blue 
stained 12% SDS-PAGE. The lane and numbers on the left represent molecular mass 
standards in kilodaltons.
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2.1.4 FITC labelling of SSLs
SSL7 and SSL9 were dialysed against labelling buffer (0.2 M NaHCCb, pH 9.0) overnight 
at room temperature (RT). 50 pi of 1 mg/ml fluorescein isothiocyanate (FITC, Sigma) in 
dimethyl sulfoxide (DMSO) was added to 1 ml of a 2 mg/ml protein solution. After 4 h 
incubation at RT in the dark, unbound FITC was removed by size exclusion 
chromatography using a PD-10 (Sephadex) column. The concentration of labelled protein, 
and the FITC:protein ratio were determined by spectrophotometry. All preparations gave 
FITCiprotein ratios of between 1:1 and 2:1.
2.2 Cell biology
All cell culture was performed under aseptic conditions in a class 2 laminar air flow safety 
cabinet, using sterile techniques. Cells were maintained by incubation at 37°C in an 
atmosphere of 5% CC>2/95% Air.
2.2.1. Cell lines
Cells were maintained in complete medium (CM) (RPMI 1640 medium (Gibco) 
supplemented with 10% fetal calf serum (FCS; PAA Laboratories), 100 U/ml penicillin, 
100 pg/ml streptomycin, and 2 mM L-glutamine (Clare Hall Laboratories, Imperial Cancer 
Research Fund), and split twice a week.
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Table 2-1 Cell lines used in this study
Cell lines Description
K562 Human erythroleukemic cell line
HL-60 Human promyelocytic leukemia cells
THP-1 Human acute monocytic leukemia cells
U937 Human monocytic leukaemia cell line
KG1 Human acute mylogenous leukaemia
WMPT EBV-transformed human B cell lines
WMPT 3.3 EBV-transformed human B cell lines
Fc7 EBV-transformed human B cell lines
2.2.2. Cell viability
Cell viability was assessed by Trypan Blue exclusion assay. 10 pi of cell suspension was 
diluted in an equal volume of 0.04% Trypan Blue solution. 10 pi of this mix was loaded 
on a haemocytometer counting chamber (Neubauer) placed under the microscope and 
white live cells (dead cells turn blue) were counted within a 4 x 4 square grid.
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2.3 Cellular immunology
2.3.1 Antibodies
The following monoclonal antibodies (MAbs) were used: CD2 (mouse MAb MAS 593, 
IgG2bi Harlan), CD3 (supernatant mouse MAb UCHT1, IgGi; gift from P. C. L. Beverley 
[Edward Jenner Institute for Vaccine Research, Compton, UK]), CD 14 (supernatant mouse 
MAb HB246, IgG2t>; gift from P. C. L. Beverley), and CD 19 (supernatant mouse MAb 
BU12, IgGi; gift fromD. Hardie [Birmingham University, Birmingham, UK]), HLA-DR 
(supernatant mouse MAb L243, IgG2a; gift from P. C. L. Beverley), HLA-ABC (W6/32; 
Serotec), CD86 (supernatant mouse MAb BU63, IgGi; gift from D. Hardie), and CD54 
(Mouse IgG MEM-111, gift from Prof. Horejsi, Academy of Science, Prague, Czech 
Republic). Fluorescein isothiocyanate (FITC) conjugated anti-mouse rabbit polyclonal 
antibody was purchased ffomDako. PE-conjugated anti-CD la (Monoclonal Mouse IgGi, 
clone BL6, Immunotech, Marseille, France). A rabbit polyclonal antibody to His-SSL7 
was produced under contract by Eurogentec Ltd (Southampton, UK) and validated by 
Western blot and ELISA.
2.3.2 Dendritic cell preparation
All blood samples were collected from healthy volunteers after informed consent had been 
obtained, following approved departmental safety protocols. The project (93/2684) was 
approved by the UCLH Ethics committee.
Human peripheral blood mononuclear cells (PBMC)-derived dendritic cells (DC) were 
generated from fresh whole blood samples obtained from healthy volunteers (Alderman et 
al., 2002; Newton et al., 2003).
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2.3.2.1 D a y l
60 ml of blood containing anticoagulant (heparin), were diluted by an equal volume of 
Hank’s Buffered Saline Solution (HBSS). 30 ml of diluted blood were carefully layered 
onto 17.5 ml of Lymphoprep (Nycomed Pharma) in a 50 ml tube (Falcon) and centrifuged 
at 400 X g  (1600rpm), at room temperature (RT). After centrifugation for 30 minutes, 
mononuclear cells in the interface were removed, diluted in HBSS and centrifuged at 400 
g for 10 minutes at RT. Cells were pooled, washed twice in HBSS and centrifuged at 
1400 rpm for 5 minutes at RT. The cell pellet was resuspended in 10 ml red blood cell 
(RBC) lysis buffer (Sigma) for 5 minutes at RT, to remove contaminating RBC. Then the 
cells were washed twice in HBSS, and the pellet was resuspended in 18 ml of complete 
medium (CM) (RPMI 1640 medium (Gibco) supplemented with 10% fetal calf serum 
(FCS; PAA Laboratories), 100 U/ml penicillin, 100 pg/ml streptomycin, and 2 mM L- 
glutamine (Clare Hall Laboratories, Imperial Cancer Research Fund). Cells were 
incubated in 6-well tissue culture plates for 2 h at 37°C in 5% CO2 . Non-adherent cells 
(T and B cells) were removed, washed and centrifuged at 1400 rpm for 5 minutes. The 
cell pellet was resuspended in 3 ml of 90% FCS: 10% dimethylsulphoxide (DMSO) mix, 
aliquoted and stored at -70°C until future use.
The adherent cells were cultured in 3 ml fresh CM with 100 ng/ml human recombinant 
granulocyte-macrophage colony-stimulating factor (GM-CSF) and 50 ng/ml interleukin 
(IL)-4 (Schering-Plough Research Institute).
66
Chapter 2 Materials & Methods
23.2.2 Day 4
6 ml o f loosely adherent cells were collected, and carefully layered onto 4 ml of 
Lymphoprep in a 15 ml tube (Falcon) and centrifuged at 400 X g(1600rpm), at RT for 30 
minutes. Cells from the interface were removed, washed 3 times in HBSS and centrifuged 
as described above. Contaminating T and B lymphocytes were removed by incubation 
with CD3, CD2, and CD 19 MAbs for 30 minutes on ice. The cells were washed in cold 
HBSS, resuspended in 2 ml of CM and mixed with anti-mouse IgG-coated 
immunomagnetic Dynabeads (Dynal) at ratio of lOpl beads/106 contaminating cells and 
incubated on a rotor mixer at 4°C, for 45 minutes. DCs were purified by removing the 
supernatant after placing the cell suspension/magnetic bead mix in contact with magnet 
for 10 minutes. The supernatant, containing highly purified DC was cultured for another 3 
days at concentration of lxlO6 cells/ml in fresh CM containing GM-CSF and IL-4 as 
described above.
2.3.3 T cells isolation
T cells were frozen at -70°C as described above on day 1 of cell preparation. On day 8, 
cells were defrosted quickly, washed twice in HBSS and centrifuged at 1400 rpm for 5 
minutes at RT. Monocytes and B cells were depleted by incubation with CD 19, HLA-DR 
and CD 14 Mabs, for 30 minutes on ice. The cells were washed in cold HBSS, 
resuspended in 2 ml of CM and mixed with anti-mouse IgG-coated immunomagnetic 
Dynabeads (Dynal) at ratio of lOpl beads/106 contaminating cells and incubated on a rotor 
mixer at 4°C, for 45 minutes. T cells (greater than 90% purity as measured by expression 
of CD3, and lack of B cell, NK or monocyte markers) were recovered from the cell 
suspension after placing of suspension/magnetic bead mix in contact with a magnet for 10
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minutes. This method also removed 10% of T cells that express HLA-DR and therefore 
are considered to be activated (Pollara et al., 2003).
2.3.4 T cell proliferation assay
2.3.4.1 Protocol 1
DCs were serially diluted and incubated at 37°C with autologous T cells (105 cells/well) 
with or without 10 pg/ml SSL proteins in flat-bottomed 96-well microtiter plates. 
500 U/ml recall antigen purified protein derivative (PPD) of Mycobacterium tuberculosis 
(Evans Medical) or lOpg/ml of Tetanus toxoid (TT) were used as positive controls. The 
cell cultures were incubated for 6 days at 37°C, in a 5% CO2 . Cells were pulsed with 1 
mCi H-thymidine (ICN Biomedical) for 16 h and harvested. T cell proliferation was 
measured by liquid scintillation counting for 3H-thymidine incorporation. All assays were 
performed in triplicate and the results are expressed as counts per minutes (cpm).
2.3.4.2 Protocol 2
DCs (104) were incubated for 6 days with autologous T cells (2 x 105) in presence of 
different concentrations of SSL7 or SSL9 (0.42, 1.25 and 4.16 pM) in flat-bottomed 96- 
well microtiter plates. 500 U/ml recall antigen purified protein derivative (PPD) of 
Mycobacterium tuberculosis (Evans Medical) was used as positive control. The cell 
cultures were incubated at 37°C, 5% CO2 .
To study the effect of SSL proteins on presentation capacity of DC, purified DCs (104), 
either untreated or treated for 18 hours with different concentrations of SSL proteins 
(4.16, 1.25 and 0.42 pM), were incubated at 37°C/5% CO2 with autologous T cells(2xl05
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cells/well) in the presence PPD or with allogeneic T cells in flat-bottomed 96-well 
microtiter plates. The DC autologous and allogeneic T-cell cocultures were incubated for 
6 days. All assays were then pulsed with 1 pCi of [3H]thymidine (ICN Biomedical, High 
Wycombe, United Kingdom) for the final 16 h of culture. Cells were harvested, and T cell 
proliferation was measured by liquid scintillation counting (Microbeta Systems). All 
assays were performed in triplicate. Results were expressed as cpm. Error bars represent 
the SD.
2.3.5 Cytokines assays
Autologous T and DCs were incubated with different concentrations of SSL proteins 
(4.16, 1.25 and 0.42 pM) at 37°C/5% CO2 in 24-well plates. After 4 days, cell culture 
supernatants were centrifuged for the removal of cells and stored at -70°C. Cytokine 
detection was done by enzyme-linked immunosorbent assay (ELISA) for interleukin-10 
(IL-10, Pharmingen, UK), gamma interferon (IFN-y, Pharmingen, UK) and IL-13 
(ImmunoTools, Germany). Purified protein derivative (PPD; 500 U/ml) was used as a 
positive control.
2.3.6 Macrophage cell preparation
Human PBMC-derived macrophages were obtained using the same procedure as used for 
DC culture (section 2.3.2), except that 10% human serum was used and no cytokines were 
added (Swetman et al., 2002).
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2.3.7 Flow cytometry
2.3.7.1 DC phenotypic analysis
DC phenotypic analysis was performed on day 8. DCs were incubated in Hanks’s 
buffered saline solution (HBSS, Gibco) with 10% normal rabbit serum (RS) for 15 min to 
prevent non-specific binding. Cells were incubated with the relevant primary MAb for 45 
min on ice, washed 3 times, and then incubated with fluoresceinated rabbit anti-mouse 
immunoglobulin (1:20 in HBSS/10%RS) for 45 min on ice. Cells were washed, fixed in 
3.7% formaldehyde and data acquired on a FACScan flow cytometer (Becton Dickinson). 
Control samples included cells alone and an isotype control. Data were analyzed using 
CellQuest software. To analyse the effect on surface phenotype expression by SSL 
proteins, 105 cells were pre-incubated for 24 h in CM with 4.16 pM of SSL7 or SSL9 or 
with peptidoglycan (PG, 5 pg/ml, , from S. aureus, Sigma) or purified LPS (100 ng/ml, 
Salmonella Minnesota, Sigma) in 96 well U-bottomed plates at 37 °C. Cells were washed 
and stained with the relevant MAbs and examined on a FACScan flow cytometer as 
discussed above.
2.3.7.2 Binding and uptake o f  FITC labelled SSLs by human cells
Human peripheral blood mononuclear cells (PBMC) were generated from fresh whole 
blood samples obtained from healthy volunteers as described above. Binding assays were 
performed in U-bottomed 96-well microtiter plates by incubating 106 cells/well in CM 
with various concentrations of SSL-FITC (0.05-1.25 pM) for 1 h at 4°C or 37°C. In some
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experiments, 8 pM of unlabelled SSL was added to the cells together with the labelled 
protein. After incubation, cells were washed 3 times by centrifugation, fixed in 2% 
formaldehyde and examined by flow cytometry.
2.3.7.3 PBMCphenotypic analysis
In some experiments, cells were additionally stained for various surface markers after SSL 
uptake. Cells were incubated with the relevant MAb markers, CD2, CD3, CD 14, and 
CD 19 for 30 min at 4°C, washed, and then incubated in 1: 25-diluted phycoerythrein- 
conjugated goat anti-mouse immunoglobulin (PE, Jackson ImmunoResearch) for 30 min 
at 4°C. Cells were washed, fixed in 2% formaldehyde and examined using a FACScan 
flow cytometer.
2.3.7.4 Dendritic cell uptake
Dendritic cells (1 x 106/ml) were incubated for 60mins in U-bottomed 96-well microtiter 
plates at 37°C with either SSL7-FITC or SSL9-FITC in CM. The cells then washed 3 
times, fixed in 2% formaldehyde and examined by flow cytometry
2.3.7.5 Endocytosis assay
DCs (105) were incubated in CM with or without 4.16 pM of SSL7 or SSL9 for various 
times (1 or 18 hours) in 96 well U-bottomed plates at 37 °C. Different concentrations (1, 
3, 10, and 30 pg/ml) of FITC-dextran (40,000 MW) were incubated with the cells. After 1 
hour of incubation at 37°C, cells were washed in ice cold HBSS containing 0.1% azide to 
stop further endocytosis, fixed with 3.7% formaldehyde, and analysed by flow cytometry.
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The uptake of dextran is expressed as mean fluorescent intensity. For each sample at least 
5000 events gated on DCs were analysed.
2.3,7.6 Cell line binding assay
Different cell lines (Table 2.1) were cultured for 60 min at 37°C in U-bottomed 96-well 
microtiter plates with either SSL7-FITC or SSL9-FITC. The cells were washed 3 times, 
fixed in 2% formaldehyde and examined by flow cytometry.
2.3.8 Confocal microscopy
105 cells were seeded on 32mm coverslips coated (for DC only) overnight at 4°C with 
lOpg/ml fibronectin (FN, Sigma) in HBSS (Gibco). After 2 h at 37°C in CM, cells were 
incubated with SSL-FITC (1.25 pM) and/or Texas Red-dextran (lmg/ml, Molecular 
Probes) for 1 h at 37°C in CM. right). Nuclei were stained with 4,6-diamidino-2- 
phenylindole (DAPI). The coverslips were then washed 3 times in cold HBSS and fixed in 
2% paraformaldehyde. The slides were examined on a Bio-Rad confocal microscope. 
Images were acquired from 0.5-pm optical sections of individual cells.
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2.3.9 SSL-speciflc antibody detection
Human serum was collected from heparinised blood of healthy volunteers. ELISA 
microassay plates were coated for 24 h with 0.04 pM of SSL proteins dissolved in sodium 
carbonate buffer 0.1 M (pH 9.5) at 4°C (100 plAvell). After three successive washes with 
HBSS containing 0.1% Tween 20, blocking was performed with 1% skimmed milk in 
HBSS for 1 h at 37°C. The plates were washed again three times, as before, and the test 
sera diluted at 1:2000 in HBSS containing 0.1% Tween 20 were incubated with SSL 
antigen for 1 h at 37°C (preliminary studies showed that this dilution of antisera gave no 
background staining for any serum tested in control wells). After three additional washes, 
the remaining bound antibodies were incubated for 1 h at 37°C with alkaline phosphates - 
conjugated goat anti-human antibodies diluted at 1:1000 in HBSS with 0.1% Tween 20. 
Excess conjugate was removed by washing as above and a colorimetric reaction was 
carried out by addition of the chromogen OPD (o-Phenylenediamine dihydrochloride) for 
15-20 minutes. The plates were read at 405 nm to detect the optical density (OD) 
readings. A control well containing no serum was used to detect the background.
Competitive ELISA was performed by mixing (1:2000 final dilution) the sera with 
differing concentrations of SSL or a control bacterial protein Embp32 (0.08, 0.17, 0.33, 
and 0.42 pM), and then testing binding on SSL-coated plates as above.
2.4 Statistical analysis
All experiments were carried out at least twice. Where appropriate, groups were compared 
using a 2-tailed Student's t test (using Microsoft Excel). The level of significance was 
<0.05.
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2.5 Identification of SSL receptors
2.5.1 Purification of SSL receptors using SSL linked to Ni NTA agarose
Recombinant SSL proteins were expressed as discussed previously (section 2.1.1.2). Ni- 
NTA agarose was saturated with rSSL (SSL7 or SSL9) proteins by incubating 4ml of 
induced bacteria lysate with 1ml of Ni-NTA resin for 1 hour at 4°C. Afterward the resin 
(Ni-NTA-rSSLs) was packed into a column and washed with B-PER and 10 volumes of 
PBS. Two Ni-NTA-rSSL columns were used for each SSL protein (SSL7 or SSL9). In 
addition a blank column containing Ni NTA agarose without rSSL was used as a control 
to evaluate nonspecific binding. The cell line (lxlO 9 cells of WMPT 3.3) suspended in B- 
PER buffer was sonicated (IKA-WERKE) on ice for 10-15 minutes, and the sonicate was 
centrifuged at 5000 rpm for 30 minutes.
This will remove debris and the receptors will be soluble in the supernatant. The 
localization of SSL receptors in the detergent-insoluble cell fractions that were removed 
by centrifugation is also possible. The efficiency of solubilisation could be checked by 
Western blotting of the supernatant and pellet, to detect the extent of solubilisation of 
known surface expressed receptors by specific antibody. In same manner, incubation of 
the blotting membrane with SSL proteins, followed by anti-SSL or anti-histidine tag and 
the detection antibody will show if the receptor is detectable by this methodology. This 
approach was not used initially, however, because it was thought less likely that the 
integrity of the receptor and its ability to bind SSLs would survive the denaturation steps 
required for Western blot.
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Sufficient amount o f cell lysate was allowed to bind to the columns at room temperature 
for 1 hour. The columns were then washed with 10 column volumes of PBS. Finally, 
bound proteins that interact with recombinant SSLs were eluted from each column using 
8M urea (0.1M sodium phosphate pH 8), whereas SSL proteins were eluted from the Ni- 
NTA columns by decreasing the pH (4.5) of 8M urea (0.1M sodium phosphate pH 4.5). 
The material which eluted from the SSLs affmity-column was collected as 1 ml fractions, 
concentrated and separated by 10% SDS-PAGE.
2.5.2 Purification of SSL receptors using rSSL linked to NHS-activated Sepharose
NHS-activated Sepharose™ High Performance columns (Amersham, UK) were washed 
with 6 column (HiTrap 1ml) volumes of ice cold 1 mM HC1. Immediately after this 
columns were coupled overnight with 1ml of recombinant SSL protein (2 mg/ml of rSSL7 
or rSSL9) at 4°C. Afterwards, the column’s free-active groups were deactivated by 
washing with 0.5M ethanolamine, 0.5M NaCl (pH 8.3). The columns were then washed 
with 0.1M acetate, 0.5M NaCl (pH 4). A blank column was deactivated and used as 
control to evaluate nonspecific binding to the column.
Total cell lysate of WMPT 3.3 cell line was allowed to bind to the respective columns 
(NHS-rSSL7 or NHS-rSSL9) or blank NHS column at room temperature for 1 hour, the 
columns were then washed with 10 ml volumes of PBS. Finally, bound proteins that 
interact with recombinant SSLs were eluted from each column using 0.1M glycine (pH 
2.1). Eluted cell proteins purified on SSL coupled affinity-columns were collected as 1 ml 
fractions concentrated (using Microcon centrifugation filter tube, 10 kDa) and separated 
on 10% SDS-PAGE. High salt buffer (KC1) was used in an attempt to elute the cellular
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proteins that non-specifically bound to SSL proteins. Affinity columns were washed in a 
stepwise manner with 3 ml of PBS containing 0, 0.5, 1 and 2 M additional KC1, followed 
by 0.1 M glycine (pH 2.1). All fractions were collected and separated on 10% SDS-PAGE.
2.6 Proteomic analysis
2.6.1 Generating peptides by trypsin digestion of proteins
Proteins of interest were excised from gels and transferred to a clean 0.5 ml Eppendorf 
tube. Gel slices were washed three times for 15 minutes per wash in a rotary mixer with 
400|nl of 50% acetonitrile / 25mM ammonium bicarbonate (pH 8) to remove excess stain, 
Gels slices were dehydrated in 100% acetonitrile for 5 minutes, and completely dried in a 
Speed-Vac (Savant) for 20-30 minutes. Trypsin (Promega) was diluted to a concentration 
of 15 pg/ml in 25mM ammonium bicarbonate. Each gel slice was soaked with 15-20 pi of 
cold trypsin, and incubated for 16-24 hours at 37°C.
2.6.2 Peptide extraction and ZipTip C18 purification
Peptides generated by in-gel digestion (section 2.6.1) were extracted from gel slices twice 
with tri-fluoroacetic acid (TFA). 50pl of 0.1% of TFA was added to each slice and 
incubated for 60 minutes with shaking, and then the supernatant were collected in a new 
tube. Extracts were completely dried (1 hr) in a Speed-Vac. Peptides were resuspended in 
10 pi of 0.1% TFA. ZipTip Cig micro-columns (Millipore) were used to remove salts or 
organic contaminants. Each tip was conditioned with lOpl of 100% acetonitrile, and three 
washes of lOpl of 0.1% TFA. Contaminants were removed by washing the ZipTip three 
times with lOpl of 0.1% TFA.
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2.6.3 Peptide fingerprinting by MALDI-TOF MS
Peptide-containing samples were eluted from the ZipTips using 5 pi a-cyano-4- 
hydroxycinnamic acid (CHCA) matrix, made up in 0.1% TFA, 50% acetonitrile, and were 
spotted in 0.5 pi droplets onto a MALDI-TOF MS sample plate in duplicate. A calibration 
mix containing angiotensin and ACTH peptide standards (Perseptive Biosystems) were 
spotted in corresponding wells on the plate, to enable external calibration of the samples. 
The spots were allowed to dry at room temperature before being loaded into a Voyager 
DE Pro MALDI-TOF mass spectrometer. Peptide fingerprints were generated by 
ionisation of the sample/matrix complex using a 327nm Nitrogen laser with delayed 
extraction. Mass to charge ratios were calculated based on the time of flight detection of 
ions.
MALDI-TOF MS was also done by Dr Steven Howell, division of protein structure, 
National Institute for Medical Research, London.
2.6.4 Identification of proteins by database searching
Proteins were identified using Protein Prospector v3.5 software. Briefly, representative 
isotopic peak masses obtained by MALDI-TOF MS analysis were used to search the 
NCBI database using Protein Prospector v3.5 software.
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CHAPTER III
Cellular tropism of staphylococcal superantigen like proteins
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3. Cellular tropism of staphylococcal superantigen like proteins
3.1 Introduction
The presence of eleven members of the SSL protein family in all S. aureus strains tested 
so far, suggested that these proteins have important non-redundant biological functions as 
agents of host/pathogen interactions. In contrast to classical superantigens, SSLs do not 
show the main properties of superantigens such as polyclonal T cell activation, 
pyrogenicity, or enhancement of endotoxin shock. However, SSLs may function to 
distract the host’s immune system, but do so via entirely different molecular mechanisms 
and participate in the pathology of staphylococcal diseases.
Identification of the cellular binding partner for the SSL proteins would be a milestone for 
understanding and determination of the function(s) of these secreted proteins. Moreover, 
this would also provide information on the involvement of these proteins in the 
pathogenicity of S. aureus. A first step in characterising the SSL function and its cellular 
receptors is to identify whether SSL interacts selectively with cells of the immune system. 
Therefore, the main objective of this chapter was to investigate the interaction of SSL7, 
and its close homologue SSL9, with different cells of the immune system.
In an attempt to design a strategy to assess whether these proteins have the ability to bind 
to PBMCs, the recombinant SSL proteins were expressed, purified and directly labeled 
with FITC. FITC labeled SSLs were then allowed to interact with various immune cells 
and analysed by the mean of flow cytometry.
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3.2 Results
3.2.1 Interaction of SSL proteins with PBMCs
Peripheral blood mononuclear cells (PBMC) (Fig. 3-1) were incubated with various 
concentrations of SSL7-FITC or SSL9-FITC for 1 h, and cell-associated fluorescence 
measured by flow cytometry. Both SSL7 (Fig. 3-2 A) and SSL9 (Fig. 3-2 B) stained a 
small proportion of PBMC at 37°C, but not at 4°C. The level of fluorescence was dose- 
dependent over the range tested (0 - 1.25 pM). The mean percentage of cells stained with 
1.25 pM of SSL7 (9.8±1.8, range 7.1-12.2, n=7) and 1.25 pM of SSL9 (10.9±1.1, range 
9.4-12.6, n=5) was very similar. Mean fluorescence also increased with time between 5 
minutes and 120 minutes (Fig. 3-3) suggesting progressive uptake of SSL protein by the 
cells.
In order to determine whether the interaction between SSL protein and PBMC was 
specific, competitive inhibition of SSL-FITC cell labelling by unlabelled SSL was 
investigated (Fig. 3-4). Excess unlabelled SSL7 was able to completely block uptake of 
SSL7-FITC. In contrast, neither SSL9, nor an unrelated bacterial protein also carrying a 
polyhistidine tag (Embp32) had any effect on the SSL7-FITC signal. Conversely, only 
unlabelled SSL9, but not SSL7 or Embp32, blocked uptake of SSL9-FITC. Interaction 
between SSL proteins and the PBMC therefore occurs via a specific receptor, and is not 
mediated by the histidine tag on these proteins. Furthermore, SSL7 and SSL9 use 
different receptors, or different sites within one receptor.
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Figure 3-1 Flow cytometry: forward scattered (FCS) / side-scatter (SSC) dot plot of 
PBMCs.
Cells in the circular gate were isolated from normal individuals and used for SSL binding 
assay by FACScan.
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Figure 3-2 Dose and temperature dependence of SSL uptake by PBMCs.
PBMCs were incubated for 60 minutes with varying concentrations of SSL7-FITC (A) or 
SSL9-FITC (B) at 37°C or 4°C, and the binding was measured by flow cytometry. The 
numbers show the percentage of uptake of SSL proteins by PBMCs. These graphs are 
representative of 10 separate experiments earned out with PBMCs from healthy donors.
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Figure 3-3. Time dependence of SSL uptake by PBMCs.
PBMCs were incubated for various times with 1.25 pM of SSL7-FITC or SSL9-FITC at 
37°C, and the uptake was measured by flow cytometry. This graph is representative of 3 
separate experiments carried out with PBMCs from healthy donors.
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Figure 3-4. Inhibition of binding of SSL-FITC to PBMCs by unlabelled SSL protein.
Different concentrations of SSL7-FITC (A) or SSL9-FITC (B) were incubated with 
PBMCs with or without 8 pM of uniabelled SSL7, SSL9 or Embp32 protein, and the 
uptake was measured by flow cytometry. Results shown are from one representative 
experiment of three. The right panels show the percentage of inhibition observed at 
different ratios of unlabelled to labelled SSL7 and SSL9.
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3.2.2 Characterisation of PBMC sub-population targeted by SSL proteins
The PBMC sub-populations which are the targets for SSL7 and SSL9 were further 
characterised by immunophenotyping, using monoclonal antibodies to the major surface 
markers CD2, CD3, CD14, and CD19. Both SSL7 and SSL9 (Fig. 3-5 and 3-6) were taken 
up by all CD 14 positive cells, and by a population of CD2-low cells, a phenotype 
consistent with that of peripheral blood monocytes (Crawford et al., 1999). Neither SSL7 
nor SSL9 showed any interaction with CD3 positive T cells. Interestingly, SSL7-FITC but 
not SSL9-FITC stained a subpopulation of CD 19 B cells, providing further evidence that 
the receptor for these two SSLs is distinct.
In order to confirm that the binding of SSLs to PBMCs was not affected by the presence 
of the histidine tag, SSL7 was subcloned into pGEX-4T-l, expressed, and purified, and 
the GST tag was then removed by cleavage with thrombin. FITC-labelled SSL7 lacking a 
tag showed binding characteristics very similar to those of the histidine-tagged version 
(Fig. 3-7). In particular, both versions of SSL7 bound to only a subpopulation of HLA- 
DR-expressing cells, suggesting that the proteins did not bind directly to this receptor.
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Figure 3-6 Immunophenotype of PBMC that interact with SSL proteins. PBMCs were stained for various cell surface markers after 
incubation with 1.25 pM SSL7-FITC or SSL9-FITC for 60 minutes at 37°C. This graph is representative of 5 separate experiments.
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Figure 3-7. Comparison of staining observed with SSL7-FITC with the histidine tag 
(SSL7h) (graphs on the right) and without the histidine tag (graphs on the left).
Immunophenotype of PBMC that interact with SSL proteins. PBMCs were stained for 
various cell surface markers after incubation with 1.25 pM SSL7-FITC for 60 minutes at 
37°C, and the uptake was measured by flow cytometry
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3.2.3 Uptake of SSL proteins by dendritic cells
Peripheral blood monocytes were cultured in vitro in the presence of GM-CSF and IL-4, 
in order to drive their differentiation into myeloid dendritic cells (Sallusto and 
Lanzavecchia, 1994). After depletion of residual lymphocytes, the population obtained 
after seven days culture consisted of >90% CDla+ HLA-DRhigh CD141ow dendritic cells 
(Fig. 3-8). These cells were incubated for 60mins at 37°C with either SSL7-FITC or 
SSL9-FITC and examined by flow cytometry and confocal microscopy (Fig. 3-9 and 3- 
10). Dendritic cells stained uniformly strongly positive for both SSL7 and SSL9. 
Confocal microscopy confirmed that fluorescence was predominantly due to intracellular 
uptake of SSL, rather than surface staining. Both SSL7 and SSL9 were concentrated in 
small vesicular structures, localised particularly to the perinuclear region of the cell.
In order to characterise the nature of these vesicles further, dendritic cells were cultured in 
the presence of SSL7 or SSL9-FITC and Texas Red dextran (Fig. 3-11), which is avidly 
taken up by DC via mannose receptors (Sallusto et al., 1995). Texas Red dextran strongly 
labelled a large number of intracellular vesicles throughout the DC cytoplasm. SSL 
distribution and dextran distribution partially overlapped, with some intracellular vesicles 
clearly containing both markers. However, SSL positive dextran negative vesicles were 
also observed. In a small proportion of cells, vesicles containing SSL9 appeared to 
aggregate, to generate very large vesicles, which contained high concentrations of both 
SSL and dextran (Fig. 3-11). The very large vesicles observed (which were never seen in 
the presence of dextran alone) presumably resulted from fusion of many SSL containing
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vesicles, and may have been driven by intramolecular interactions between SSL 
molecules. Similar vesicle distortion is observed in the presence of excess invariant chain, 
again driven by multiple interactions between invariant chain molecules (Romagnoli et 
ah, 1993).
In order to determine whether uptake of SSLs was a generalised feature of endocytic cells, 
peripheral blood monocytes were differentiated into macrophages, via culture in human 
serum, without added cytokines. Under these culture conditions, the cells develop a 
completely different phenotype (CDla-,HLA-DR-,CD14high) and morphology (lack of 
dendrite formation) (Swetman et ah, 2002). Macrophages, like DC efficiently 
endocytosed Texas Red dextran, but showed no uptake of either SSL7 or SSL9 (Fig. 3-12 
and 3-13).
Other fluorescent dye such as Alexa Fluor could be used as an alternative to FITC for 
SSL proteins labelling to rule out any possibility of FITC quenching by the lower pH of 
the endosomal acidic vesicles in macrophages.
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Figure 3-8. Phenotypic analysis of DC
(A) Forward scatter/side scatter dot plot of DC. Cells in the elliptical gate have 
characteristic (size/granularity) of DC. (B) Day 7 DCs were isolated, incubated with 
MAbs and analysed by FACScan. The indicated markers are shown by the blue 
histograms, whereas cells either alone (thick line) or stained (dotted line) with relevant 
isotype control MAb are indicated by the open line histograms. Results shown are from 
one donor and are representative of similar data obtained from experiments carried out 
with DC from three different donors.
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Figure 3-9. SSL proteins binding to PBMC-derived dendritic cells (DC).
CDla+ DCs (unpurified) derived from CD 14+ cells were incubated with different 
concentrations of SSLs conjugated with FITC. The cells were fixed and analysed by flow 
cytometry, measuring SSL as FL1 (horizontal) and CDla by FL2 (vertical). The numbers 
show the percentage of SSL positive cells that were also CDla positive. This figure is 
representative of a set of 3 separate experiments carried out with DCs from healthy 
donors.
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Figure 3-10. SSL proteins binding to PBMC-derived dendritic cells (DC).
Purified DCs derived from CD14+ cells were incubated with 1.25 pM of SSL conjugated 
with FITC. Binding was analysed by flow cytometry (left panel) and confocal microscopy 
(right panel). Nuclei are stained with DAPI and shown in blue. This figure is 
representative of a set of 3 separate experiments carried out with DCs from healthy 
donors.
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Figure 3-11. Intracellular localization of SSL proteins in human PBMC-derived 
dendritic cells (DC).
Dendritic cells were cultured in the presence of 1.25 pM SSL7 or SSL9-FITC with or 
without 1 mg/ml Texas Red dextran for 60 minutes, 37°C. Cells were analysed by means 
of confocal microscopy. The images shown are representative of 6 separate experiments.
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Figure 3-12. Intracellular uptake of SSL proteins by PBMC-derived dendritic cells 
(DC) and PBMC-derived macrophages.
Cells were incubated with 1.25 pM SSL9-FITC for 60 minutes. 37°C. The images shown 
are representative of 3 separate experiments.
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Figure 3-13. Intracellular uptake of SSLs by PBMC-derived dendritic cells and 
PBMC-derived macrophages.
Cells were incubated with 1.25 SSL7-FITC and 1 mg of Texas Red dextran per ml for 
60 min at 37°C. The results are representative of the results of three separate experiments
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3.3 Discussion
The characteristic features of the interaction between SSL7 and SSL9, and PBMC are 
specificity, temperature dependence and cell selectivity. Specificity, indicative that the 
interaction is mediated by a cell surface receptor, is shown by the demonstration that 
unlabelled SSL blocks uptake of SSL-FITC. This competition is observed for both SSL7 
and SSL9. The lack of reciprocal inhibition between SSL7 and SSL9 suggest that these 
two molecules have different binding partners on the cell surface, although we cannot rule 
out the possibility that they bind to different sites on the same molecule. Due to 
limitations in the concentration of labelled SSL proteins, we could not determine the 
amount of SSL proteins that were able to saturate the putative receptors. Since it was 
impossible to measure binding in the absence of uptake, true measurements of affinity 
could not be obtained. The concentrations required to obtain measurable uptake, however, 
were in the order of 0.1 micromolar, suggesting that the affinity of interaction with any 
putative receptor is relatively low. This is a characteristic of many classical superantigens 
(Labrecque et al., 1993), and also of many receptors of the innate immune system (e.g. 
mannose receptors, (East and Isacke, 2002; Sallusto et al., 1995). Inhibition of SSL 
proteins uptake by cytochalasinD or colchicine, inhibitors for microfilaments or 
microtubules respectively, would be useful approaches to understand the cellular uptake 
mechanism for this family of proteins.
The temperature and time dependence of SSL interaction are suggestive of receptor 
mediated uptake rather than simple binding to the cell surface, and this was confirmed by 
the confocal microscopy studies discussed further below. However, a small amount of 
surface binding can be detected at 37°C, but not 4°C, using indirect labelling of intact
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cells with an antibody against the histidine tag (not shown). The interaction of SSL with 
the receptor, as well as its subsequent uptake, is therefore temperature-dependent.
The third characteristic o f SSLs observed in these cellular studies with PBMC was the 
highly selective nature of the target population with which interaction could be detected. 
In ex vivo PBMC, the major target population is the monocyte, characterised by high 
expression of CD 14. Essentially all monocytes were found to interact with both SSL7 and 
SSL9. In contrast, neither SSL7 nor SSL9 interacted with T cells, identified by expression 
of CD3 and high levels of CD2. Interestingly, SSL7, but not SSL9 also bound to a 
proportion of B cells (in the order of 30% although this varied significantly between 
individuals), providing further evidence that the receptor for these two molecules is 
distinct. The B cell sub-population which interacts with SSL7 could be CD5 cells as less 
than 30% of circulating B cell in adults are positive to this marker (Youinou et al., 1999), 
but this was not investigated further in this study. Since a very significant proportion of T 
cells and all human B cells also express class II MHC (e.g. HLA-DR) this result rules out 
a direct binding of SSL7 or SSL9 to these molecules, thus clearly distinguishing them 
from classical superantigens.
Monocytes express both class I and class II MHC molecules, and can act as antigen 
presenting cells for the activation of CD4 or CD8 T cells. However, the prototype antigen 
presenting cell, and the only cell type which can activate naive T cells, is the dendritic 
cell. It was therefore of interest that both SSL7 and SSL9 were taken up efficiently by 
monocyte-derived DC. This cell type, which can be obtained by culture of PB monocytes 
with appropriate cytokines, provides a widely used model for myeloid dendritic cells.
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In contrast, neither SSL7 nor SSL9 showed any tropism for macrophages, a cell type also 
produced by in vitro culture of monocytes, but which does not present antigen except 
when stimulated by appropriate cytokines, such as IFNy. This result suggests that 
macrophages do not express receptors for SSLs proteins. Although macrophages may take 
up SSLs via nonspecific mechanisms (i.e., macropinocytosis), the concentrations of 
labelled protein used are likely to be too low to detect this uptake. Further experiments to 
see whether macrophages can be induced to express the SSL receptor following activation 
would be of interest.
Confocal studies on intracellular co-localization of SSL-FICT proteins would highlight 
the possible staphylococcal target strategy within DCs. Staining of endocytic vesicles 
such as class II MHC (MHC loading compartment), cathepsins (proteinases in Ag 
processing) or ER-specific markers BiP (GRP78) in antigen presenting cells (see section 
5.2.5) may be of interest.
99
Chapter 4 Functional studies of DCs exposed to SSL proteins
CHAPTER IV
Functional studies of dendritic cells exposed to 
Staphylococcal superantigen-like proteins
100
Chapter 4 Functional studies of DCs exposed to SSL proteins
4. Functional studies of dendritic cells exposed to SSL proteins
4.1 Introduction
In the previous chapter we demonstrated the interaction between two members (SSL7 and 
SSL9) of the SSL protein family and human immune cells. These proteins target 
themselves selectively to APCs such as monocytes and DC, leading to progressive uptake 
and internalisation by these cells. Dendritic cells have a key function in initiating and 
connecting both arms of the immune response. Therefore, we hypothesised that S. aureus 
may use SSL proteins as an evasion strategy to induce alterations in the functional 
properties o f DC, such as DC maturation, uptake, and antigen presentation as well as DC- 
mediated T cell activation, preventing their normal function and thus moderating the 
response of the host to the bacterium. In this chapter, we test this hypothesis.
The other objective of this chapter was to determine the immunological response to the 
SSL proteins in the normal human population. Very little work has been carried out 
previously on T cell responses to S. aureus. Therefore, the proliferative and cytokine 
responses of T cells, as well as the antibody response against these proteins were 
examined to demonstrate the presence and type of T cell specific response toward this 
family of proteins, and the presence of specific SSL antibodies in this population of 
normal individuals.
101
Chapter 4 Functional studies of DCs exposed to SSL proteins
4.2 Results
4.2.1 The effects of SSL proteins on DC viability, morphology and surface 
phenotype
Monocyte-derived DCs (MDDC) were derived from PB monocytes. They showed the 
characteristic phenotype of immature DC; low CD 14, and high HLA-DR and high CD la 
(see Fig 3-8). As shown previously (see section 3.2.3), flouresceinated SSL7 and SSL9 
labelled DC in purified cultures, containing less than 5% non-DC.
DCs were incubated with SSL7 or SSL9 (4.16 pM) for either 1 or 18 hours at 37°C, and 
cell viability was assessed by trypan blue exclusion. Microscopic analysis revealed that 
SSL proteins were not cytotoxic as more that 95% of cells appeared viable. Untreated 
cells were predominantly non-adherent with few dendritic cell processes, typical of 
immature DC (Fig 4-1). Neither SSL7 nor SSL9 induced any noticeable morphological 
changes over the time period tested. In contrast DCs treated with the TLR4 bacterial 
ligand LPS (100 ng/ml) or the TLR2 ligand peptidoglycan (PG) (5 pg/ml) became 
adherent and extended multiple, long dendritic processes (Fig 4-1).
The cell-surface expression o f a panel of characteristic DC surface markers was analyzed 
by flow cytometry. Immature DCs were incubated with 4.16 pM of SSL7 or SSL9, or LPS 
or PG and the surface phenotype of these DCs was analyzed after 18 h of culture. Neither 
SSL7 nor SSL9 (Fig 4-2) induced significant changes in any of the surface molecules 
measured. In contrast, DCs incubated with either LPS or PG up-regulated surface 
expression of HLA-DR, HLA-ABC, CD86, and CD54. Thus, in summary, exposure of
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DCs to the SSLs protein did not induce DC maturation, nor indeed any obvious changes 
in DC surface phenotype, viability or morphology.
SSL9
Figure 4-1 Morphology of DC treated with SSL proteins.
DC were cultured in the presence of 4.16 pM SSL7 or SSL9 for 18 hours at 37°C. 
Lipopolysaccharide (LPS, 100 ng/ml) and peptidoglycan (PG, 5 pg/ml) were used as 
positive controls. The numbers in the top right comer show the percentage of cells which 
were trypan blue negative. Representative of 3 experiments.
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Figure 4-2. Phenotypic analysis of DC treated with SSL proteins.
Data are shown for expression of cell surface molecules on DC that had been treated for 
18 h with 4.16 pM SSL7 or SSL9. Lipopolysaccharide (LPS, 100 ng/ml) and 
peptidoglycan (PG, 5 pg/ml) were used as positive controls. Expression of the indicated 
markers is shown by the solid histograms, whereas cells stained with control mAh are 
indicated by the open line histograms. The numbers on each histogram correspond to the 
median fluorescence intensity (MFI) of mAb staining. Results shown are from one donor 
and are representative o f similar data obtained from experiments carried out with DC 
from four different donors.
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4.2.2 The influence of SSLs on endocytosis
Fluorescein isothiocyanate-labelled dextran (FITC-Dx) is rapidly taken up by DCs via the 
mannose receptor (Sallusto et al., 1995). To determine whether SSL protein altered DCs 
antigen uptake function, DCs were treated with 4.16 pM of SSL7 or SSL9 and incubated 
for 1 or 18 hours at 37°C. Different concentrations of FITC-Dx were added to the cell and 
incubated for a further hour at 37°C, and FITC-Dx uptake by the DC was then measured 
by flow cytometry. As shown in Fig 4-3, SSL treated DC showed rapid uptake of FITC- 
Dx, and neither protein had any effect on endocytic activity.
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Figure 4-3. Endocytosis of FITC-Dx by DCs exposed to SSL proteins.
DCs were incubated for (A) 1 hour or (B) 18 h in presence or absence of SSL7 or SSL9 
(4.16 pM). Excess proteins were removed by washing, and the cells were incubated with 
different concentrations o f FITC-dextran (1, 3, 10, and 30 pg/ml). Excess dextran was 
removed by washing, and the cells were fixed. The total cell associated dextran was 
measured by flow cytometry, and expressed as mean fluorescent intensity for a minimum 
of 5000 DC. The results o f one of three separate experiments are shown.
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4.2.3 The influence of SSLs on T cell stimulatory capacity of DCs
To evaluate the effect o f SSL proteins on the stimulatory capacity of DC in T cell 
proliferation, day 6 DCs were incubated for 18 hours with different concentrations of SSL 
proteins (0.42, 1.25 and 4.16 pM). Residual T cells were depleted and the functional 
assays performed using fresh viable purified autologous or allogeneic T cells. The ability 
to induce secondary immune responses was unchanged. Figure 4-4A shows representative 
experiments eliciting recall responses to tuberculin (PPD). There was no statistical 
difference in the proliferative responses observed between any of the pre-incubated DC 
groups with SSL7 or SSL9 (37182 ± 2036 cpm and 36458 ± 3000 cpm, respectively) and 
the control (36458 ±6151 cpm) after the 6 days co-culture period (P >0.05).
The capacity o f SSL-treated DCs to elicit primary T cell proliferation also was tested in an 
allogeneic mixed lymphocyte reaction (MLR). A similar result was observed (Fig 4-4B), 
the proliferation response against allogeneic T cell (25710 ± 1140 cpm) was unaffected by 
exposure to SSL7 or SSL9 (26149 ± 3674 and 25816 ± 3159 cpm, respectively, (P  >0.05). 
Therefore, SSL proteins have no effect on the ability to induce proliferation of allogeneic 
T cells. In general, the results o f these experiments demonstrated that the antigen 
presentation capacity o f DCs remains intact in the presence of these secreted proteins.
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Figure 4-4. Effect of SSL proteins on T cell stimulatory capacity of DCs.
A DCs (104) were treated with increasing concentrations of SSL7 or SSL9 (0.42, 1.25 
and 4.16 ^M), and cultured for 18 h before the addition of autologous T cells (2 x 105) in 
the presence of purified protein derivative (PPD; 500 U/mL). Data are mean ± SD of 5 
experiments. (M; medium).
B DCs were (104) treated with increasing concentrations of SSL7 or SSL9 (0.42, 1.25 
and 4.16 pM) and cultured for 18 h before the addition of allogeneic T cells (2 x 105). 
Data are mean ± SD of 3 experiments. Proliferation was assessed by incorporation of 3H- 
thymidine.
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4.2.4 The immunological response to SSLs in the normal human population
4.2.4.1 T cell responses
To investigate the ability o f SSLs to stimulate the recall T cell respond in healthy 
volunteers, DCs were incubated with autologous T cells from normal donors in the 
presence o f 0.42 pM  SSL7 or SSL9. Purified protein derivative (PPD) and Tetanus toxoid 
(TT) were used as positive controls. Figure 4-5 indicates that no or very low T cell 
proliferation in 6 normal volunteers was induced by these proteins. This suggests that this 
family o f proteins has no superantigenic activity. The effect o f a higher protein 
concentration (2.1 pM o f SSL7) on T cell proliferation was also tested. A positive T cell 
response was found to this concentration o f SSL7 in 2 of 3 individuals (Fig 4-6).
These results highlight the possible requirement for higher in vitro SSL proteins 
concentration to be processed and presented and induce a cellular T cell response. 
Moreover, the T cell specific for the SSL protein may be present at low precursor 
frequency. In the next series o f experiments, therefore, the responses in eight healthy 
donors were studied with relatively large numbers of T cells/well (2x10 ) against DCs 
preloaded with higher concentrations o f SSL proteins
The results o f these experiments (Fig. 4-7 and 4-8) documented the presence of a recall 
response against this family of proteins in 3 normal subjects (j 7%) from the sample 
population (8 volunteers; 2 females, six males, age range 20-50, median approximately 
30) screened. All volunteers showed a good recall response against PPD (70889 ±3146 
rpm).
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Additional evidence for an antigen-specific response was also examined. T cell cytokine 
secretion was determined to document the type of the response specifically; whether the 
response is skewed towards Thl or Th2. The supernatants of the 3 DC/T cell/SSL 
co-culture (individuals 1, 2 and 8 from Figs 4-7 and 4-8) were tested for IFN-y (Thl), IL- 
13 (Th2), and IL-10 (Treg). All cytokine levels were low (IFNy < 700pg/ml n=3); IL-13< 
50 pg/ml, n=3) or undetectable (IL-10). The results for the individual with maximum 
response (individual 1 in Fig 4-7) at different SSL concentrations are shown in Fig 4-9.
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Figure 4-5. Autologous T cell responses to SSL proteins.
DCs were incubated with autologous T cells (106) with or without 0.42 pM of SSL 
proteins, and the proliferation was measured by 3H-thymidine incorporation. Purified 
protein derivative (PPD; 500 U/ml) was used as positive control. Data are representative 
of 6 experiments curried out on cells from normal individuals
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Figure 4-6. Autologous T cell responses to SSL proteins.
DCs were incubated with autologous T cells (106) with or without 2.1 of SSL7 protein, 
and the proliferation was measured by 3H-thymidine incorporation. Tetanus toxoid (TT; 
10 fxg/ml) was used as positive control. Results shown are from one experiment. 
* P<0.05.
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Figure 4-7. T cell responses to DC loaded with SSL protein.
DCs (104) were incubated for 6 days with autologous T cells (2 x 105) in presence of different 
concentrations of SSL7 or SSL9 (0.42, 1.25 and 4.16 pM). Data are mean ± SD of triplicate 
cultures from individual experiments. Proliferation was assessed by incorporation of 3H- 
thvmidine.
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Figure 4-8. T cell responses to DC loaded with SSL protein.
DCs (104) were incubated for 6 days with autologous T cells (2 x 105) in presence of different 
concentrations of SSL7 or SSL9 (0.42, l .25 and 4.16 pM). Data are mean ± SD of triplicate 
cultures from individual experiments. Proliferation was assessed by incorporation of 3H- 
thvmidine.
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Figure 4-9. Effects of SSL protein on cytokine production.
DCs (104) were incubated for 4 days with autologous T cells (2 x 105) in presence of 
different concentrations of SSL7 or SSL9 (0.42, 1.25 and 4.16 pM) and purified protein 
derivative was used as control (PPD; 500 U/mL).
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4.2.4.2 Antibodies responses
In order to see if the presence of a T cell response correlated with antibody production, 
sera from 10 individuals (3 females, 7 males, age range 20-50, median approximately 30, 
including those tested for T cell responses as shown above) were tested by ELISA against 
immobilised SSL7 and SSL9 (Fig. 4-10). Nine out of ten individuals tested showed 
antibody responses to both SSL7 and SSL9 at this dilution, consistent with a previous 
report of antibodies against SSL proteins in normal volunteers (Arcus et al., 2002). 
Interestingly, competitive ELISA (Fig. 4-11) showed that the antibody response was 
highly specific for individual SSL isotypes. Increasing concentrations of SSL7 (Fig. 4- 
11 A) were able to completely block the interaction between SSL7 protein and SSL7 sera. 
In contrast, neither SSL9, nor an unrelated bacterial protein (Embp32) had any effect on 
the SSL7 antibody binding. Conversely, only SSL9, but not SSL7 or Embp32, were able 
to block SSL9-antibody (Fig. 4-1 IB). Therefore, interaction between SSL proteins and 
the SSL-antibodies were specific and do not cross-react.
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Figure 4-10. Antibody responses to SSLs in human sera.
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Figure 4-11. Antibody responses to SSLs in human sera.
Serum from sample 1 above (Figure 4-10) was diluted 1:2000 (final dilution) and mixed 
with varying concentrations of SSL7, SSL9 or Embp32 as shown. The sera were then 
added to plates coated with either SSL7 (A) or SSL9 (B) as shown. One experiment of 
two.
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4.3 Discussion
We originally showed that SSL proteins have the ability to interact with cells of the 
immune system including monocytes and DC (see section 3.2). DCs as professional 
antigen presenting cells have a key role in the initiation of the immune response against 
microbial infections; therefore, many microbial strategies have been described which 
interfere with DC function (Moll, 2003). One hypothesis of SSL function suggested that 
these proteins may interfere with the normal function of DC and therefore impair the 
protective immune response to S. aureus. Such functions have recently been proposed for 
the anthrax lethal toxin (Agrawal et al., 2003) and E. coli heat labile toxin (Petrovska et 
al., 2003). This hypothesis was therefore addressed in the first part of this chapter.
SSL7 or SSL9 proteins were not toxic to antigen presenting cells nor did they alter the 
characteristic morphology of these cells. In contrast, dramatic alteration to DC 
morphology were demonstrated by Clostridium difficile toxin B, (Swetman et al., 2002). 
Conversely, SSL7 and SSL9 did not induce process extension, or up-regulation of cell 
surface co-stimulatory and HLA molecules on the DC, two characteristic signs of 
activation/maturation responses induced by whole S. aureus (Tourkova et al., 2001) or 
bacterial surface components such as PG (Michelsen et al., 2001). Thus, although SSLs 
bind to and are taken up by DC (see Figure 3.10) this interaction does not appear to 
engage activating receptors on the DC surface (similar to lectins such as mannose 
receptor).
119
Chapter 4 Functional studies of DCs exposed to SSL proteins
In light of the potential for LPS contamination, the SSLs were expressed in a lipid A E. 
coli mutant (Somerville, Jr. et al., 1996) which makes LPS with a very low inflammatory 
activity. In addition a polymixin B wash step was added to scavenge any contaminating 
LPS (see section 2.1.1). The absence of any DC maturation in the presence of these SSLs 
suggested levels of LPS were below 1 ng/ml.
In addition to their specialised dendritic morphology and cell surface phenotype, DC are 
characterised by extremely rapid endocytosis by both fluid phase and receptor mediated 
uptake (Swanson and Watts, 1995; Levine and Chain, 1993). The uptake of FITC-Dx, 
which is believed to be mediated via mannose receptors on the cell surface (Sallusto et al., 
1995) is frequently used to measure the latter. DC did indeed show efficient 
internalisation of FITC-Dx (albeit slightly less well after overnight culture) but this 
uptake was not altered by exposure to SSL7 or SSL9.
Finally, since DCs are distinguished by being the most potent stimulators of both primary 
and secondary T cell responses, we tested the effects of SSL7 and SSL9 exposure on DC 
function directly. Although DC stimulated powerful proliferative responses to both PPD 
(a classical recall secondary response to BCG vaccination) and allogeneic purified T cells 
(predominantly a primary response) neither SSL7 nor SSL9 altered the antigen 
presentation activity of DCs.
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An alternative possibility is that SSL proteins may subvert DC activation or maturation in 
response to other staphylococcal components such as PG or LTA. Such functions have 
been documented for some bacterial toxins (see section 1.2.3). Therefore, SSLs may 
inhibit up-regulation of activation markers and the production of cytokines such as 
interleukin 12 from DCs that interacted with these modulators. This impairment could be 
the SSL proteins contributions to staphylococcal infections.
Next, the immune response to SSLs was analysed in a small panel o f healthy human 
volunteers. Although none of the individuals tested had any known history of clinical 
S. aureus infection, the organism is extremely prevalent in the environment and 
approximately 30-40% of individuals are colonised by S. aureus, usually in the nasal 
mucosa (Nair et al., 2000). Indeed in eight volunteers tested, three (37%) showed a dose 
dependent T cell response to DC loaded with SSL9, and two to SSL7. The response was 
only detectable with relatively large numbers of T cells/well (2xl05) and induced the 
release of only very low level of either Thl (IFN-y) or Th2 (IL-13) cytokines, suggesting 
that the precursor frequency of T cells specific for SSL was likely to be low.
The response to SSL7 and SSL9 was also assessed at the humoral level. Using solid phase 
ELISA nine out ten sera tested showed specific antibody binding to both SSLs. The 
response measured was IgG (using an anti-IgG detection antibody) suggesting that class 
switching had occurred and further implicating the activity of SSL-specific T cells. 
Interestingly, some individuals (e.g. individuals 2 and 7) show antibody responses but no 
detectable T cells responses, perhaps because precursor T cell frequency has fallen below 
detectable levels in these individuals. One individual showed a T cell response to SSL9,
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but no antibody response to either SSL tested, although we cannot rule out that some 
antibody might be detectable at lower dilutions. These results agree with an earlier report 
of specific SSL antibody detection in human sera (Arcus et al., 2002). Interestingly, the 
antibody response to each SSL was highly specific with minimal evidence of cross-SSL 
reactivity. This data is consistent with the high sequence diversity between SSL paralogs, 
despite a highly conserved protein fold motif (Al Shangiti et al., 2004; Arcus et al., 2002).
Determination of the isotype profile of the anti-SSL response by using isotype specific 
secondary antibodies would be useful to provide alternative evidence of Thl/Th2 
skewing.
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CHAPTER V
Identification of the staphylococcal superantigen like proteins
receptor(s)
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5 Identification of the SSL proteins receptor(s)
5.1 Introduction
Identification and characterization of staphylococcal superantigen-like proteins 
receptor(s) are important in understanding the contribution that the SSL proteins may 
make to Staphylococcus aureus infection as well as the basis of the cellular tropism of 
these secreted proteins.
In an attempt to isolate the receptor(s) for SSL proteins present in several cell lines, the 
recombinant His-tag SSL proteins were expressed, purified and immobilized using NTA- 
agarose affinity chromatography and allowed to interact with cell lysates from selected 
cell lines. Once the putative receptors have been isolated, they can be further 
characterized by MALDI-TOF (matrix-assisted laser desorption/ionization time-of-flight) 
mass spectrometry analysis or N-terminal amino acid sequencing to determine their 
identity.
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5.2 Results
5.2.1 Screening of SSL proteins binding to different cell lines
Different cell lines were screened for the ability to bind SSL proteins (SSL7 and SSL9). 
Cell lines were incubated with 1.25 pM of SSL7-FITC or SSL9-FITC for 1 h, and cell- 
associated fluorescence measured by flow cytometry. As demonstrated in Fig 5-1 and 
Table 5-1, both proteins bound to various cell lines including a human acute mylogenous 
leukaemia (KG1) cell line, and different EBV-transformed human B cell lines (WMPT, 
WMPT 3.3 and Fc7). The binding to human monocytic leukemia (U937) cells was very 
weak, and there was no interaction of these proteins with the rest of the screened cells, 
human erythroleukemic (K562), promyelocytic leukaemia (HL-60), and human acute 
monocytic leukemia (THP-1) cells. The fast growing cell line WMPT 3.3, which bound to 
SSL proteins, was used for the identification of SSL proteins receptor(s), whereas K562 
cells were used as negative control.
WMPT3.3
SSL-FITC
Figure 5-1. Binding of SSL7-FITC and SSL9-FITC to various cell lines
Each cell line (1x106/ml) was incubated for 1 hour with 1.25 pM of SSL7-FITC (green 
line) or SSL9-FITC (Pink line) at 37°C, and screened for SSL protein binding by flow 
cytometry. This result is representative of 3 separate experiments carried out with each 
cell line.
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SSLs Binding
Gen lines SSL7 SSL9
K562 Negative Negative
HL-60 Negative Negative
THP-1 Negative Negative
U937
KG1 Positive Positive
WMPT Positive Positive
WMPT 3.3 Positive Positive
Fc7 Positive Positive
Table 5-1. Binding of SSL7-FITC and SSL9-FITC to various cell lines
Each cell line (1x106/ml) was incubated for 1 hour with 1.25 pM of SSL7-FITC or SSL9- 
FITC at 37°C, and screened for SSL protein binding by flow cytometry. This result is 
representative of 3 separate experiments carried out with each cell line.
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5.2.2 Purification of SSL binding proteins using Ni-NTA agarose
In order to identify proteins which interact with SSL proteins, affinity chromatography 
was used to purify SSL binding proteins. Initially, recombinant SSL proteins were 
coupled to Ni-NTA agarose through the 6-His tag located in their amino terminus (see 
section 2). Two Ni-NTA agarose columns were used, one for SSL7 and one SSL9, in 
addition to a blank column as a control to evaluate nonspecific binding to the Ni-NTA 
agarose. The WMPT 3.3 cell line was expanded until it reached 1 x 109 cells, a number 
that was considered may be sufficient to generate enough receptor protein to identify. The 
cells were lysed in lysis buffer, then nuclei and cellular debris were removed by 
centrifugation as described earlier (2.5.1).
Proteins from cell lysates were allowed to bind to the respective columns (Ni-NTA-rSSL7 
or Ni-NTA-rSSL9 or Ni-NTA) at room temperature; the columns were then washed with 
10 ml of PBS. Finally, bound proteins that interact with recombinant SSLs were eluted 
from each column using 8M urea (pH 8), whereas SSL proteins and strongly interacting 
cell proteins were eluted from the Ni-NTA columns by reducing the pH of the 8M urea to 
4.5. Solubilized cell proteins isolated on the Ni-NTA blank column, the SSL7-Ni-NTA 
column and SSL9-Ni-NTA column were collected as 1ml fractions, concentrated and 
separated on 10% SDS-PAGE. SDS-PAGE revealed (Fig 5-2, 5-3 and 5-4) that many 
proteins interacted with these proteins as well as with the blank columns. As shown in Fig 
5-2 many bands with molecular weight ranging from 30-110 kDa were bound to SSL9- 
Ni-NTA column. These bands were enriched after concentration (Fig 5-3); two bands at 
around 70-80 kDa appeared to bind to SSL9-Ni-NTA (see arrow on Fig 5-3), but not to 
the control (see further below). No bands were visible in the elution from SSL7-Ni-NTA
127
Chapter 5 Identification of the SSLs receptor(s)
by 8M urea (pH8) (Fig 5-4). A large number of proteins were eluted from both SSL7-Ni- 
NTA and Ni-NTA columns by 8 M urea (pH4.5).
More proteins bound to SSL9 than SSL7, this may be because the SSL9 protein has more 
positively charged residues (39, pi: 9.31) than SSL7 (29, pi: 6.8). Collectively these 
results suggested there was much non specific binding of cell lysate proteins to the Ni- 
NTA agarose column, making identification of a specific receptor difficult.
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M B
KDa
66
27 8M Urea pH8
66
27 8M Urea pH4.5
A : Ni-NTA-SSL9 + Cell lysate B: Ni-NTA-SSL9 only C: Ni-NTA + Cells lysate
Figure 5-2. Purification of SSL9 receptors on Ni-NTA agarose columns.
SSL9 protein was coupled to a Ni-NTA agarose column as described in the Methods. 
WMPT 3.3 cell lysates were applied to the columns and proteins which bound to SSL9 
were eluted with 8M urea (pH 8). The columns were incubated with 8M urea (pH 4.5) to 
elute SSL9 protein from the columns. The figures are a photograph of Colloidal Brilliant 
blue stained 10% SDS-PAGE.
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97
66
56
43
36
27
A : Ni-NTA-SSL9 + Cell lysate B: Ni-NTA-SSL9 only C: Ni-NTA + Cells lysate
Figure 5-3. Large SDS-PAGE using 10% gel (Colloidal Brilliant blue stained).
SSL9 protein was coupled to Ni-NTA agarose columns as described in the Methods. 
WMPT 3.3 cell lysates were applied to the columns and the proteins which bound to 
SSL9 were eluted with 8M urea (pH 8). The columns were washed with 8M urea (pH4.5) 
to elute the SSL9 protein from the columns. Two fractions were concentrated (c) by 
centrifugation. The lane and numbers on the left represent molecular mass standards in 
kilodaltons.
A1c
8M Urea pH4.5
C2c
8M Urea pH8
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A : Ni-NTA-SSL7 + Cell lysate B: ISH-NTA-SSL7 only C: Ni-NTA + Cells lysate
Figure 5-4. Purification of SSL7 receptors on Ni-NTA agarose columns.
SSL7 protein was coupled to Ni-NTA agarose columns as described in the Methods. 
WMPT 3.3 cell lysate was applied to the columns and the proteins which bound to SSL7 
were eluted with 8M urea (pH 8). The columns were washed with 8M urea (pH4.5) to 
elute SSL7 protein from the columns. The figures are a photograph of Colloidal Brilliant 
blue stained 10% SDS-PAGE. The lane and numbers on the left represent molecular mass 
standards in kilodaltons
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5.2.3 Purification of SSL receptor(s) using NHS-activated Sepharose columns
To overcome the problems of the ability of cell lysate proteins to bind to the free atoms of 
the resin on the Ni-NTA columns, we used NHS-activated Sepharose columns, in which 
the ligand is coupled covalently to the NHS-activated column though primary amino 
groups to form a very stable amide linkage, and any excess active groups that have not 
been coupled to the ligand protein can be deactivated or blocked.
Two NHS-activated columns were coupled with SSL protein (SSL7 or SSL9). 
Afterwards, the column’s free-active groups were deactivated as described in the Methods 
(See section 2). Blank columns were deactivated and used as controls to evaluate 
nonspecific binding to the column. Total cell lysate from the WMPT 3.3 cell line was 
allowed to bind to the respective columns (NHS-rSSL7 or NHS-rSSL9) at room 
temperature for 1 hour; the columns were then washed with 10 volumes of PBS. Finally, 
bound proteins that interact with recombinant SSLs were eluted from each column using 
0.1M glycine (pH 2.1). Solubilized cell proteins purified on SSL9 coupled affmity- 
column were collected as fractions (Fig. 5-5), concentrated (Fig. 5-6) and separated on 
10% SDS-PAGE. Using this methodology it was possible to reduce the binding of cell 
lysate proteins to the column. As seen in Fig 5-6 few proteins were able to bind to the 
control column (NHS + cell lysate). However, many proteins were still interacting with 
the SSL9 protein affinity column. As mentioned above, this interaction may be a result of 
ionic binding between these cell lysate proteins and highly charged SSL9 protein.
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In order to selectively remove those proteins binding via non-specific ionic interaction, 
the affinity columns were washed in a stepwise manner with 3 ml of PBS containing 0, 
0.5, 1 and 2 M additional KC1, followed by elution with 0.1M glycine (pH 2.1). All 
fractions were collected and separated on 10% SDS-PAGE.
As demonstrated in Figure 5-7, the KC1 (0.5 M) elution of the columns removed many 
proteins, which may represent non-specific binding. Additional faint bands, representing 
more tightly bound proteins, were eluted by 0.1M glycine. SSL9 binding proteins that 
eluted in 0.5 M KC1 and 0.1M glycine were concentrated (Fig. 5-8) and separated on a 
large gel (10% SDS-PAGE). Despite the salt wash, a number of different bands were 
eluted by the acid wash, including two prominent bands around 70 kDa as seen previously 
in Fig 5-3. In contrast no bands were observed after elution of the SSL7-affinity columns, 
even after concentration of the elution fractions (Figures 5-9 and 5-10). This result is the 
same as that obtained using the Ni-NTA-SSL7 column (see Fig 5-4) and may be due to 
the weak binding between this protein and the cell line.
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NHS-SSL9 + Cell lysate NHS-SSL9 only NHS + Cells lysate
M F1 F2 F3 F1 F2 F3 F1 F2 F3
Figure 5-5. Purification of SSL9 receptors on NHS-activated Sepharose columns.
SSL9 protein was coupled to NHS-activated Sepharose columns as described in Methods. 
WMPT 3.3 cell lysate was applied to the columns and proteins which bound to SSL9 
were eluted with 0.1M glycine (pH 2.1). The figures are a photograph of Colloidal 
Brilliant blue stained 10% SDS-PAGE. The lane and numbers on the left represent 
molecular mass standards in kilodaltons.
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NHS-SSL9 + Cell lysate NHS + Cells lysate
F2c F1c M
KDa
Figure 5-6. Purification of SSL9 receptors by NHS-activated Sepharose columns.
SSL9 protein was coupled to NHS-activated Sepharose columns as described in Methods. 
WMPT 3.3 cell lysate was applied to the columns and proteins which bound to SSL9 
were eluted with 0.1M glycine (pH 2.1). The figures are a photograph of Colloidal 
Brilliant blue stained 10% SDS-PAGE. Fractions were concentrated (c) by centrifugation. 
The lane and numbers on the right represent molecular mass standards in kilodaltons.
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Figure 5-7. Purification of SSL9 receptors on NHS-activated Sepharose columns.
SSL9 protein was coupled to NHS-activated columns as described in Methods. WMPT
3.3 cell lysate was applied to the columns then washed with PBS. The SSL9 bound 
proteins were eluted with increasing concentrations of KCI (0.5, 1, 2M) followed by 0.1 M 
glycine (pH 2.1). The figures are a photograph of Colloidal Brilliant blue stained 10% 
SDS-PAGE. The lane and numbers on the left represent molecular mass standards in 
kilodaltons
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glycine pH 2.1 0.5 M KCI
M F2 F3 F2 F3 F2 F3 F2 F3 M
NHS-SSL9 + Cell lysate NHS + Cells lysate NHS-SSL9 + Cell lysate NHS + Cells lysate
Figure 5-8. Purification of SSL9 receptors on NHS-activated Sepharose columns.
Fractions of SSL9 bound proteins eluted with 3ml of KCI (0.5M) and 3ml of 0.1M 
glycine (pH 2.1) were concentrated by centrifugation. The figures are a photograph of 
Colloidal Brilliant blue stained large ID SDS-PAGE (10%). The lane and numbers on the 
left represent molecular mass standards in kilodaltons
137
C hapter 5 Identification of the SSLs receptor(s)
NHS-SSL7 + Cell lysate NHS-SSL7 only NHS + Cells lysate
M F1 F2 F3 F1 F2 F3 F1 F2 F3
Elution
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pH 2.1
Figure 5-9. Purification of SSL7 receptors on NHS-activated Sepharose columns.
SSL7 protein was coupled to NHS-activated Sepharose columns as described in Methods. 
WMPT 3.3 cell lysate was applied to the columns then washed with PBS. The SSL7 
bound proteins were eluted with increasing concentrations of KCI (0.5, 1, 2M) followed 
by 0.1M glycine (pH 2.1). The figures are a photograph of Colloidal Brilliant blue stained 
10% SDS-PAGE.
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Figure 5-10. Purification of SSL7 receptors on NHS-activated Sepharose columns.
Fractions (3ml) of SSL7 bound proteins eluted with KCI (0.5, 1, 2M) and 0.1M glycine 
(pH 2.1) were concentrated by centrifugation. The figures are a photograph of Colloidal 
Brilliant blue stained 10% SDS-PAGE. The lane and numbers on the left represent 
molecular mass standards in kilodaltons
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5.2.4 Identification of proteins which bound non-specificaily to SSLs-affinity 
columns
The human erythroleukemic (K562) cell line was among the cell lines that showed no 
binding to SSL proteins as demonstrated by flow cytometry (see section 5.1.2). Therefore, 
this cell line was used as a negative control to identify proteins in cell lysates which 
bound non-specifically to the SSL affinity columns and thus try to identify those proteins 
from the WMPT3.3 cell lysates that were interacting specifically with the SSL proteins.
Total cell lysate of WMPT 3.3 and K562 cell lines were allowed to bind to NHS-rSSL7 
and NHS-rSSL9 column or blank columns at room temperature for 1 hour. The columns 
were then washed with 10 ml of PBS, followed by washing in a stepwise manner with 3 
ml of PBS containing 0.5, 1 and 2 M KCI. Finally, bound proteins that interact with 
recombinant SSLs were eluted from each column using 0.1M glycine (pH 2.1). 
Solubilized cell proteins from both cell lines purified on SSL7 or SSL9 coupled affinity- 
columns or blank columns were collected as fractions and separated on 10% SDS-PAGE 
(Fig. 5-11), or concentrated and separated on large gel (Fig. 5-12). Many protein bands 
were observed after concentration of elution fractions from both cell line lysates. 
However, a single clear band was visible in WMPT3.3 eluates but not from K562 eluates, 
with a molecular weight of around 70 kDa (Fig. 5-12).
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NHS-SSL7 NHS-SSL7 NHS-SSL9 NHS-SSL9 NHS NHS
WMPT 3.3 K562 WMPT 3.3 K562 WMPT 3.3 K562 NHS-SSL9 
WMPT 3.3
NHS-SSL9
K562
Figure 5-11. Purification of SSLs receptors on NHS-activated Sepharose columns.
SSL7 and SSL9 proteins were coupled to NHS-activated columns as described in 
Methods. WMPT 3.3 or K562 cell lysates were applied to the columns then washed with 
PBS. The SSL7 bound proteins were eluted with increasing concentrations of KCI (0.5, 1, 
2M) followed by 0.1M glycine (pH 2.1). The figures are a photograph of Colloidal 
Brilliant blue stained 10% SDS-PAGE. Figure on the right is enlargement of selected 
areas. The arrow indicates the 70 kDa band of interest.
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Figure 5-12 . Purification of SSLs receptors by NHS-activated Sepharose columns.
A) SSL7 and  SSL9 proteins were coupled to NHS-activated columns as described in 
Methods. W M PT 3.3 or K562 cell lysates were applied to the columns then washed with 
PBS. The SSL bound proteins were eluted with KCI (0.5M) and 0.1M glycine (pH 2.1) 
and concentrated by centrifugation. The arrow indicates the 70 KDa proteins of interest. 
The figures are a photograph of Colloidal Brilliant blue stained large SDS-PAGE (10%). 
The lane and numbers on the left represent molecular mass standards in kilodaltons.
B) Enlargem ent o f selected area.
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5.2.5 Protein identification by peptide mass fingerprinting
In order to identify the protein band obtained from large gel (Fig 5-12), the 70 kDa band 
was excised and subjected to tryptic digestion, and the resulting peptide mixture was 
analysed by MALDI-TOF mass spectrometry (carried out by Dr S. Howell, NIMR, 
London). Using this method we identified the protein as heat shock 70kDa protein 5 
(glucose-regulated protein, 78kDa) or BiP (Table 5-2).
Table 5-2. Protein identified by MALDI-TOF fingerprints
Accession no. MOWSE
Score
Mass Protein
Description
16507237 7.198e+04 72402 Heat shock 70kDa protein 5
(Protein Prospector) (glucose-regulated protein,
78kDa); BiP
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5.3 Discussion
Cellular infection by bacteria is a multistep process, whereby some bacteria or bacterial 
products attach to the cell via host cell surface molecules and then initiate the 
internalization process. We suggested previously (see section 3.2.1) that the SSL proteins 
bind to cells of immune system through specific but different binding partners or binding 
sites. In an attempt to identify the putative receptors for this family of proteins from 
selected cell lines, we used affinity chromatography and mass spectrometry to isolate and 
identify the SSL receptors. Proteomic analysis revealed that heat shock 70kDa protein 5 
(glucose-regulated protein 78kDa (GRP78) also known as BiP (heavy chain binding 
protein), was a candidate receptor for SSL9.
Cells exposed to stressful conditions, such as high temperatures, oxidative injury, heavy 
metals, and proinflammatory cytokines, increase synthesis of a multifunctional group of 
proteins referred to as stress proteins or heat shock proteins (HSPs). They have been 
designated as a member of the larger family of proteins called molecular chaperones 
(Moseley, 2000). These proteins are classified into families according to their molecular 
mass (ranging from 110 to 8 kDa), and serve as cellular chaperones, participating in 
protein synthesis and transport through the different cellular compartments, and can bind 
a wide variety of targets (for review see (Kiang and Tsokos, 1998; Srivastava, 2002)).
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HSPs are among the most abundant intracellular cytoplasmic molecules present in both 
eukaryotic and prokaryotic cells, under both unstressed and stressed conditions (Moseley, 
2000). However, several studies have suggested that some members of this family such as 
HSP60, HSP70 and HSP90 are also expressed on the surface of cells (Arap et al., 2004; 
Guzhova et al., 1998; Multhoff and Hightower, 1996; Triantafilou et al., 2002).
BiP (GRP78) was originally identified independently as the immunoglobulin heavy chain 
binding protein (Haas and Wabl, 1983) and as the glucose regulated protein (Pouyssegur 
et al., 1977). Like other HSP70 proteins, BiP has two major domains, an N-terminal and 
C-terminal domains, with 61% and 66% amino acid sequence identity with that of HSP70 
and HSC70 proteins, respectively. The C-terminal binding domain fold of BiP is similar 
in all members o f the HSP70 protein family (Gething, 1999; Munro and Pelham, 1986). 
grp78 gene expression is increased in response to cellular stresses, including glucose 
starvation, accumulation of unglycosylated proteins and oxygen deprivation (Gething, 
1999). BiP is a resident luminal endoplasmic reticulum (ER) protein that binds to patches 
of hydrophobic amino acids (Flynn et al., 1991; Foy and Matsuuchi, 2001). It has several 
function, including acting as a molecular chaperone in antigen presentation, catalysing the 
folding and translocation of nascent polypeptide chains including the folding and 
assembly of MHC I molecules, and it has also been suggested that it protects cells from 
ER stress (Morris et al., 1997).
146
Chapter 5 Identification of the SSLs receptor (s)
Several studies have shown that BiP (GRP78) can also be expressed on the cell surface 
(Arap et al., 2004; Delpino and Castelli, 2002; Shin et al., 2003). Shin et al (2003) (Shin 
et al., 2003) confirmed an abundance of ER chaperone proteins (including BiP) on the cell 
surfaces of five different cell lines. Interestingly, BiP (GRP78) has recently been 
identified as a co-receptor protein for non-enveloped Coxsackievirus A9 (Triantafilou et 
al., 2002). In this system, BiP acts as a binding protein for the virus while MHC class I 
mediate virus internalization. More recently, Jindadamrongwech et al (2004), 
(Jindadamrongwech et al., 2004) have demonstrated that BiP also functions as receptor 
for dengue virus serotype 2.
The experiment which identified BiP as a candidate receptor for SSL proteins was 
undertaken only once due to the project time limits, so further experiments to confirm 
these finding are needed. In addition to repeating the biochemical isolation, several 
additional pieces of evidence are required to confirm whether BiP (GRP78) is indeed the 
SSL receptor. These will include examining whether BiP is expressed on the surface of 
monocytes and DCs by flow cytometry. Further validation should include transfection of 
a BiP cDNA into a non-binding cell line (such as K562 or T cell) to demonstrate the 
conversion of the cell line to a binding one. Antibodies against BiP may also be tested for 
their ability to block SSL binding.
At this stage, identification of BiP as the SSL receptor must be considered preliminary, 
especially as the ability to bind ‘non-specifically’ to many proteins is one of the 
characteristic features of this chaperone family.
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Nevertheless, binding o f bacteria with ER proteins has been documented previously. 
Talilleux et al (2003) (Tailleux et al., 2003) have found that a significant proportion of 
mycobacterial phagosomes stained strongly for the ER-specific markers BiP (GRP78) in 
antigen presenting cells and suggested this co-localization could be a specific 
mycobacterial ER-targeting strategy.
In a different context, it has been reported that monocytes become apoptotic following 
phagocytosis of S. aureus, and that this bacterium can induce selective expression of 
HSP70 in these cells (Kantengwa and Polla, 1993). Moreover, it has been reported that 
the expression of HSP72 provides efficient protection against apoptosis triggered by 
phagocytosis of S. aureus by monocytes (Guzik et al., 1999). So, it is tempting to 
speculate that the binding of SSL proteins to this chaperone family might be a bacterial 
strategy to block a protective activity provided by chaperones to the immune cells.
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6. General Discussion
The major role o f the immune system is to identify and eliminate pathogens. Cells of the 
immune system are well equipped for sensing pathogens and their products or danger 
signals delivered from infected cells. DCs have been recognised as an important cell 
population that are able to link pathogen detection with regulation of the adaptive immune 
responses. Many microbial strategies have therefore evolved to induce alterations in the 
functional properties of these professional antigen presenting cells, preventing their 
normal function and thus moderating the response of the host to the bacterium (Moll, 
2003).
The pathogenicity o f Staphylococcus aureus is multi factorial, generally involving a large 
number of extracellular proteins. Some of these proteins, including cytotoxins and 
exoenzymes, are secreted; others, including protein A and various adhesins, remain 
attached to the cell wall. Together, these proteins enable the organism to evade host 
defences, adhere to host cells and intercellular matrix molecules, invade or destroy host 
cells, and spread within the tissues (Proft and Fraser, 2003).
Production of many different exotoxins by a single bacterium may reflect the nature of the 
multiplication strategy of S. aureus in the human body (Kuroda et al., 2001). Several 
bacterial species have developed a system of evading the host immune system as a 
microbial strategy for survival. However, S. aureus seems to challenge the immune 
responses of the host by initiating local inflammation and subsequent abscess formation.
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This localization of bacteria inside the abscess may help S. aureus to concentrate the 
secreted proteins and enzymes which have the ability to destroy the cells of immune 
systems and surrounding tissues.
The number of staphylococcal SAgs identified has increased due to various S. aureus 
genome sequencing projects (Baba et al., 2002; Fitzgerald et al., 2003; Kuroda et al., 
2001; Orwin et al., 2001; Orwin et al., 2003). In 2000, a novel gene cluster in the 
staphylococcal genome was identified that harboured at least five related genes with the 
characteristic SAg family signature. The corresponding gene products were originally 
named staphylococcal enterotoxin-like toxins (SET) (Williams et al., 2000). Members of 
this protein family were recently renamed the staphylococcal superantigen-like (SSL) 
proteins (Lina et al., 2004). Two SSLs (SSL5 and SSL7) have been crystallized and the 
structure determined revealing a typical SAg fold. However, so far none of the SSLs have 
exhibited any of the functional hallmarks of all SAgs, such as MHC class II binding or T 
cell stimulation. Thus, while they are structurally related, they appear to have very 
different functions (Al Shangiti et al., 2004; Arcus et al., 2002).
The function of SSLs is still unknown, but their location within a pathogenicity island in 
all S. aureus strains tested so far, as well as the presence of SSL specific immunity in so 
many individuals, and the existence of so many SSL paralogs in the S. aureus genome, is 
suggestive of a strong interaction between host immunity and evolution of this bacterial 
family of proteins. One possibility is that SSL7 and SSL9 induce alterations in the 
functional properties of these cells, preventing their normal function and thus moderating 
the response of the host to the bacterium. An alternative possibility, however, is that like 
classical superantigens, SSLs may allow S. aureus to stimulate a non-protective immune
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response and thus to distract the protective adaptive immune response of the host, and 
contribute to bacterial pathogenicity. The uptake of SSL7 and SSL9 into an endosomal 
compartment which intersects with the dextran uptake pathway is certainly compatible 
with such a role, since uptake via the mannose receptor efficiently targets antigens to the 
Class II MHC antigen processing pathway (Sallusto et al., 1995).
Limited information is available on the direct effect of S. aureus and its toxins - apart 
from SAgs - on DCs, in particular on their subsequent ability to induce T cell 
proliferation, which is a fundamental step in the human adaptive immune system. This 
information is important because it may highlight the cellular interaction occurring during 
innate as well as adaptive immune responses against S. aureus in the course of infection. 
Thus, we studied the ability of SSL treated DCs to stimulate recall T cell responses in 
healthy individuals as well as the ability to stimulate responses to SSLs themselves. T cell 
recall responses to SSLs were observed in some individuals, complementing the known 
antibody response to these proteins.
A number of bacterial strategies have been documented by which bacteria avoid detection 
and elimination by the immune system via interfering with DC function (described in the 
general introduction, see section 1.2.3). We have found that SSL proteins (SSL7 and 
SSL9) fail to up-regulate DC’s surface activation markers or their endocytic activity. 
Furthermore, DCs treated with SSL proteins have the same antigen presentation activities 
to stimulate both allogeneic response (processing independent responses) and a recall 
response to PPD (processing dependent). Therefore, the antigen presenting cell activity is 
not adversely affected by the presence of SSLs. Conversely, self-targeting to antigen 
presenting cells may result in enhancing the immunogenicity of these proteins. Although
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enhancing immunogenicity would, at first sight, appear to be paradoxical, the generation 
of an antibody response to a secreted protein is unlikely to confer any advantage to 
bacterial clearance by the host. On the contrary, the interaction between secreted toxin 
and specific antibody in the microenvironment of the bacterium may activate complement 
and hence contribute to the breakdown of the physical barriers which restrict the 
invasiveness o f these bacteria.
The final chapter of the thesis describes a preliminary identification of BiP (GRP78), a 
glucose-regulated protein belonging to the heat shock 70 family of proteins, as candidate 
receptor for SSL proteins. BiP has been identified as a viral receptor and has been 
implicated as chaperone in antigen presentation and delivery of peptides to MHC 
molecules in ER lumen. In view of our finding one could suggest a model wherein SSL 
utilizes BiP, a MHC-associated protein, as receptor or binding molecule for attachment to 
the cell surface followed by internalisation and thus gains access to the cell’s machinery. 
The antigens enter the endolysosomal pathway, where proteins are digested and load onto 
class II molecules for presentation to T cells. So, it is tempting to speculate that the 
binding of SSL proteins to this chaperone would be a bacterial strategy to prevent antigen 
presentation activity o f the immune cells. One example of immune evasion carried out in 
this manner is the bacterium H. pylori, which secret vacuolating protein toxin (VacA) 
(Reyrat et al., 1999) that causes vacuolation of acidic endocytic compartments; this 
elevation of endolysosomal pH decreases lysosomal protease activity. Therefore, the 
generation of class Il-specific peptides may be impaired, as may the proper proteolytic 
cleavage o f the invariant chain molecules (Satin et al., 1997; Molinari et al., 1998; 
Hudson and Ploegh, 2002).
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In conclusion, this study describes some of the functional consequences of the interaction 
between SSL and DC. In contrast to some other bacterial exotoxins (Agrawal et al., 2003; 
Petrovska et al., 2003) SSLs do not appear to damage DC, but rather can be taken up by 
them, and thus stimulate T cell responses in a significant fraction of healthy individuals. 
Further studies will be necessary to demonstrate whether this immune response is of 
potential benefit to the bacteria or the host. Taken together, therefore, these data do not 
provide any evidence that SSL proteins inhibit or modify DC function, although we 
cannot rule out the possibility that they act on some function as yet untested.
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Future work
This investigation has generated many questions that would be of interest to follow up 
through further experiments. Some of the possible future directions have already been 
addressed in relevant chapters. Here some outline strategies for future work that may be 
of particular interest.
• Assessment of the effect of SSL proteins on monocyte differentiation to DC as 
well as antigen presentation capacity of monocytes to activate allogeneic T cell 
proliferation and cytokine production.
• Comparison of the immunological response to SSL proteins in individuals with 
recent clinical Staphylococcus aureus infection to those from the normal 
population.
• Characterisation of the B cell sub-population which interacts with SSL7.
• Examination o f the expression of BiP (GRP78) protein on the surface of 
monocytes and DCs and assessment of the effect of antibodies against this protein 
to block SSL/DC binding.
• Assessment of the effect of SSL proteins on DC phagocytosis to whole S. aureus 
bacteria and its migration ability.
• Investigation of the ability of these proteins to bind mouse DCs, an approach to in 
vivo studies.
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User
Email
Search title 
Database 
Taxonomy 
Timestamp 
Top Score
Ali
1
NCBInr 20040105 (1590839 sequences; 520945819 residues) 
Homo sapiens (human) (101738 sequences)
7 Dec 2004 at 16:26:58 GMT
129 for gi|6470150, BiP protein [Homo sapiens]
Probability Based Mowse Score
Score is -10*Log(P), where P is the probability that the observed match is a random event. 
Protein scores greater than 63 are significant (p<0.05).
25 H
X
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40
JSL i
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*
30 100 120 140
Probability Based Mouse Score
Protein Summary Report
To create a bookmark for this report, right click this link: Protein Summary Report (1)
Re-Search All Search Unmatched
Index
Accession Mass Score
1. gi 6470150 71002 129
2. gi 87528 72185 128
3. gi 16507237 72402 128
4. gi 37546003 39484 52
5. gi 563444 11055 50
BiP protein [Homo sapiens]
dnaK-type molecular chaperone HSPA5 precursor - human
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa); BiP
hypothetical protein XP_353073 [Homo sapiens]
Ig heavy chain (VH4) V region (VDJ) [Homo sapiens]
Results List
1. gi|6470150 Mass: 71002 Score: 129
BiP protein 
Observed
997.535 
1191.659 
1210.622 
1528.764 
1555.802 
1566.792 
1801.905 
1815.976 
1833.890 
1887.965 
1933.993 
2016.042
[Homo 
Mr (
996
1190
1209
1527
1554
1565
1800
1814
1832
1886
1932
2015
sapiens 
expt)
. 527 
. 651 
. 614 
.756 
.794 
.784 
. 897 
.968 
.882 
.957 
.985 
. 034
Mr (
996
1190
1209
1527
1554
1565
1800
1814
1832
1886
1933
2015
calc)
.510 
. 629 
. 578 
.739 
.786 
.773 
. 889 
. 989 
.902 
.964 
.006 
. 059
± ppm Start End Miss Peptide
17.2 280 - 288 0 ALSSQHQAR
18.2 447 - 456 0 VYEGERPLTK
30.1 3 5 9 -  368 1 EFFNGKEPSR
11.3 307 - 318 1 AKFEELNMDLFR 1 Oxidation (M)
5.1 29 - 42 1 NGRVEIIANDQGNR
7.5 43 - 56 0 ITPSYVAFTPEGER
4.4 541 - 555 1 IDTRNELESYAYSLK
-11.5 180 - 196 1 IINEPTAAAIAYGLDKR
-10.6 6 4 -  79 1 NQLTSNPENTVFDAKR
-3.5 1 4 7 -  163 0 VTHAWTVPAYFNDAQR
-10.6 4 5 7 -  474 0 DNHLLGTFDLTGIPPAPR
-12.2 1 4 6 -  163 1 KVTHAWTVPAYFNDAQR
http://10.40.1.86/mascot/cgi/master_results.pl?file=. ./data/20041207/F007367.dat 12/7/04
Mascot Search Results: Protein View Page 1 of 2
V'SmS'iuu NIMR Customised Mascot Protein View
Search title: 1.. .(click here for default protein view)
Match to gi|6470150 BiP protein [Homo sapiens]
Cleavage by Trypsin: cuts C-term side of KR unless next residue is P 
Datafile: ../data/20041207/F007367.dat (rank: 1)
Taxonomy: Homo sapiens
BLAST gi|6470150 at NCBI against nr
Matched peptides shown in Bold Black and unmatched H, K, R in Red
1
7 1
1 4 1
211
2 8 1
3 5 1
4 2 1
4 9 1
5 6 1
6 3 1
MEEDKKEDVG 
ENTVFDAKRL 
AY LGKKVTHA
TFDVSLLTID
LSSQHQARIE
PK1QQLVKEF
RNTVVPTKKS
LRVTAEDKGT
KEKLGGKLSS
AELHHHHHH
TVVGIDLGTT
IGRTWNDPSV
WTVPAYFND
NGVFEWATN
IESFYEGEDF
FNGKEPSRGI
Q1FSTASDNQ
GNKNK1T1TN
EDKETMEKAV
YSCVGVFKNG
QQDIKFLPFK
AQRQATKDAG
GDTHLGGEDF
SETETRAKFE
NPDEAVAYGA
PTVTIKVYEG
DQNRLTPEEI
EEKIEWLESH
RVEIIANDQG
VVEKKTKPYI 
TIAGLNVMRI 
DQRVMEHFIK 
ELNMDLFRST 
AVQAGVLSGD 
ERPLTKDNHL 
ERMVNDAEKF 
QDADIEDFKA
NRITPSYVAF
QVDIGGGQTK
INEPTAAAIA
LYKKKTGKDV
MKPVQKVLED
QDTGDLVLLD
LGTFDLTGXP
AEEDKKLKER 
KKKELEEIVQ
TPEGERLIGD
TFAPEEISAM
YGLDKREGEK
RKDNRAVQKL 
SDLKKSD1DE 
VCPLTLGIET 
PAPRGVPQ1E 
IDTRNELESY 
PIISKLYGSA
AAKNQLTSNP
VLTKMKETAE 
NILVFDLGGG 
RREVEKAKRA 
IVLVGGSTRI 
VGGVMTKLIP 
VTFEIDVNGI 
AYSLKNQIGD 
GPPPTGEEDT
Nominal mass of protein (M ) : 71002 Sequence Coverage: 25%
Masses for matched peptides shown in bold black in the following list:
Masses of unobserved peptides ([HR] containing, completely cleaved & unmodified) are shown in blue
Start - End Observed Calc. ± ppm Miss
244 - 250 903.476 0
515 - c,22 986.516 o
280 - 288 997.535 997.518 17.2 0
506 514 1074.554 0
447 - 456 1191.659 1191.637 18.2 0
359 - 368 1210.622 1210.586 30.1 1
168 - 179 1217 . 631 0
32 - 42 1228 . 629 0
309 - 318 1313 . 620 0
336 - 349 1460 .760 0
307 - 318 1512.752 1
307 - 318 1528.764 1528.747 11.2 1
29 - 42 1555.802 1555.794 5.1 1
43 - 56 1566.792 1566.780 7.4 0
541 - 555 1801.905 1801.897 4.3 1
180 - 196 1815.976 1815.997 -11.5 1
64 - 79 1833.890 1833.909 -10.6 1
147 - 163 1887.965 1887.972 -3.5 0
457 - 474 1933.993 1934.014 -10.6 0
584 - 599 1974 . 908 0
475 - 492 1999.086 0
146 - 163 2016.042 2016.067 -12.2 1
289 - 306 2164 . 993 0
43 - 63 2235.079 2235.166 -39.0 1
616 - 639 2626 .182 0
201 - 243 4567 . 227 0
Mean error = 13.9 ppm
Sequence
( . . D Q R )V M E H F IK ( LY K . . )
{ . . QNR) L T P E E IE R  ( MYT3 . . )
ALSSQHQAR
( . . K N K )IT IT N D Q N R ( L T P . . )
VYEGERPLTK
EFFNG K EPSR
( . . ATK) DAGTIAGENVMR ( U N  . . )
( . . N G R )V E 11A N D Q G N R ( I T P . . )
( . .RA K ) FEELNMDL.FR (STM . . )
( . . L K K )S D ID E IV L V G G S T R ( I P K . . )
AKFEELNMDLFR
AKFEELNMDLFR 1 Oxidation (M)
NG RVEIIANDQG NR  
ITP SY V A FT PE G E R
i d t r n e l e s y a y s l k
IIN E PT A A A IA Y G L D K R  
NQLTSNPENTVFDAKR  
VTHAW TVPAYFNDAQ R  
D NH LLG TFDLTG IPPAPR
. . E E K )IE W L E SH Q D A D IE D FK (A K K . . )
. . A P R )G V P Q IE V T F E ID V N G IL R (V T A . . )  
KVTHAW TVPAYFNDAQR
. Q A R )IE IE S F Y E G E D F S E T L T R (A K F . . )  
ITPSY V A FTPEG E R LIG D A A K  
. . ISK )LYG SAG PPPTG EEDTAELH H H H H H ( . . )
. . GEK) NILVFDLGGGTFDVSLLTIDNGVFEW ATNGDTHLGGEDFDQR
Sort peptides by: Residue Number •  Increasing Mass Decreasing Mass
FTP lists to TOF-MS No •  Yes — Annotation label: I1
Potential phosphorylation? •  No Yes
Potential anom olous c leavages? •  No Yes
Lysine containing m issed pep tides? •  No Yes
Append entrez report? •  No Yes
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c n t o  .
CD
1
1200
Opld SAH
SMPNAM 041207_leon_ali_marisa.
AQ_DATE Tue Dec 7 15:(39:28
PATH /data
POLARI POS
AQOP_m Reflector
TD 100000
NoSHOTS 200
SMONUM 0
SM0PTS1 0
SMOPTS2 0
SMOPTS3 0
DW 0.50 Ins]
DELAY 28000 [ns]
Uisl 26.00 [kv]
Uis2 21.20 [kv]
Uref 1 29.90 [kV]
Ulens 13.00 [kV]
Uhimass 10.00 (kV)
RefFull 29.90 [kV]
UdetL 1.40 [kV]
UdetR 1.65 [kV]
Udefl 2 . 00 [kv]
REPHZ 10.00 f Hz]
ATTEN 70.0
ML1 731027 . 837
ML 2 231.762
ML 3 0.013
HITURBO no 
GDEON yes 
GDEDLY short 
DEFLON yes 
RLNSBND no 
LLNSBND no 
UIS2BND no
DPCAL1 1415.27
DPMASS 725.00 [DaJ
RBNDVAL 0.33
LBNDVAL 0. 50
IS2BNDV 0.80
CMTl t
CMT2 last / 1 0/ none / non
CDLO
I MluUL*jWNjkNLwiiiNli
- ProtParam Tool http://ca.expasy.org/cgi-bin/protparar
ExPASv Home oase Site Map Search ExPASv Contact us SWISS-PROT Proteomics tools
ProtParam tool
User-provided sequence:
1 11 21 31 41 51
I I I I I I
1 MRGSHHHHHH GSAEKQERVQ HLHDIRDLHR YYSSESFEYS NVSGKVENYN GSNVVRFNPK 60
61 DQNHQLFLLG KDKEQYKEGL QGQNVFVVQE LIDPNGRLST VGGVTKKNNK TSETNTPLFV 120
121 NKVNGEDLDA SIDSFLIQKE EISLKELDFK IRQQLVNNYG LYKGTSKYGK IIINLKDENK 180
181 VEIDLGDKLQ FERMGDVLNS KDIRGISVTI NQI
References and documentation are available.
N u m b e r  o f  a m i n o  a c i d s :  213 
M o l e c u l a r  w e i g h t :  24439.3 
T h e o r e t i c a l  p i :  6.80
A m in o  a c i d  c o m p o s i t i o n :
Ala (A) 2 0.9%
Arg (R) 9 4.2%
Asn (N) 19 8.9%
Asp (D) 14 6.6%
Cys (C) 0 0.0%
Gin (Q) 13 6.1%
Glu (E) 16 7.5%
Gly (G) 17 8.0%
His (H) 10 4.7%
H e (I) 14 6.6%
Leu (L) 19 8.9%
Lys (K) 20 9.4%
Met (M) 2 0.9%
Phe (F) 8 3.8%
Pro (P) 3 1.4%
Ser (S) 16 7.5%
Thr (T) 7 3.3%
Trp (W) 0 0.0%
Tyr (Y) 8 3.8%
Val (V) 16 7.5%
Asx (B) 0 0.0%
Glx (Z) 0 0.0%
Xaa (X) 0 0.0%
T o t a l  n u m b e r  o f  n e g a t i v e l y  c h a r g e d  r e s i d u e s  ( A s p  +  G lu )  : 30 
T o t a l  n um be r  o f  p o s i t i v e l y  c h a r g e d  r e s i d u e s  ( A r g  + L y s )  : 2 9
A t o m i c  c o m p o s i t i o n :
Carbon C 107 4
30/01/2002 14:0(
5ASy - ProtParam Tool http://ca.expasy.org/cgi-ui; i/j. -'arani
Hydrogen H 1700
Nitrogen N 312
Oxygen 0 337
Sulfur s 2
F o r m u l a :  C1 0 7 4 H1 7 0 0 N 312O3 3 7 S 2 
T o t a l  n u m b e r  o f  a t o m s :  3425
E x t i n c t i o n  c o e f f i c i e n t s :
Conditions: 6.0 M guanidium 
0.02 M phosphat* 
pH 6.5
Extinction coefficients are
276 
nm
Ext. coefficient 11600
Abs 0.1% (=1 g/1) 0.475
hydrochloride
buffer
in units of M 1 cm-1 .
278 279 G S Q  282
nm nm nm nm
11200 10760 10240 9600
0.458 0.440 y 0.419J 0.393
E s t i m a t e d  h a l f - l i f e :
The N-terminal of the sequence considered is M (Met).
The estimated half-life is: 30 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
I n s t a b i l i t y  i n d e x :
The instability index (II) is computed to be 15.71 
This classifies the protein as stable.
A l i p h a t i c  i n d e x :  83.15
G r a n d  a v e r a g e  o f  h y d r o p a t h i c i t y  (G R A V Y ): -0.822
ExPASv Home page I Site Map ExPASv 1 Contact us ISWISS-PROT Proteomics tools
2 30/01/2002 14:06
*y .  Tuiranun iuui nup://ca.cx.pcisy.uig/ugi-uni/piuipcii am
s e t s
ExPASv Home uase Site Map Search ExPASv Contact us Swiss-Prot Proteomics tools
ProtParam tool
User-provided sequence:
1 11 21 31 41 51
I I I I I I
1 MRGSHHHHHH GSQTVNAKVK LDETQRKYYI NMLKDYYSQE SYESTNISVK SEDYYGSNVL 6 0
61 NFNQRNKNFK VFLIGDDRNK YKELTHGRDV FAVPELIDTK GGIYSVGGIT KKNVRSVFGY 12 0
121 VSHPGLQVKK VDPKDGFSIK ELFFIQKEEV SLKELDFKIR KMLVEKYRLY KGASDKGRIV 180
181 INMKDEKKHE IDLSEKLSFD RMFDVLDSKQ IKNIEVNLN
References and documentation are available.
N u m b e r  o f  a m i n o  a c i d s :  219 
M o l e c u l a r  w e i g h t :  25606.1 
T h e o r e t i c a l  p i :  9.31
A m in o  a c i d  c o m p o s i t i o n :
Ala (A) 3 1.4%
Arg (R) 10 4 . 6%
Asn (N) 14 6 . 4%
Asp (D) 16 7 .3%
Cys (C) 0 0 . 0%
Gin (Q) 7 3.2%
Glu (E) 15 6 . 8%
Gly (G) 14 6 .4%
His (H) 9 4 . 1%
lie ( I) 14 6 .4%
Leu (L) 16 7 .3%
Lys (K) 29 13 .2%
Met (M) 5 2 .3%
Phe (F) 11 5 . 0%
Pro (P) 3 1.4%
Ser (S) 17 7 . 8%
Thr (T) 6 2 .7%
Trp (W) 0 0 . 0%
Tyr (Y) 12 5 . 5%
Val (V) 18 8 .2%
Asx (B) 0 0 . 0%
Glx (Z) 0 0 . 0%
Xaa (X) 0 0 . 0%
T o t a l  n u m b e r  o f  n e g a t i v e l y  c h a r g e d  r e s i d u e s  ( A s p  + G lu )  : 31 
T o t a l  n u m b e r  o f  p o s i t i v e l y  c h a r g e d  r e s i d u e s  ( A r g  + L y s ) : 39
A t o m i c  c o m p o s i t i o n :
Carbon C 114 7
Hydrogen H 1807
11/02/2003 13:25
- ProrPau.. y .org/cgi-bin/protparam
N i t r o g e n  N 3 1 7
Oxygen 0 3 3 8
Sulfur S 5
Formula: C1147H 1807N 317O338S5 
Total number of atoms: 3 614
Extinction coefficients:
Conditions: 6.0 M guanidium hydrochloride 
0.02 M phosphate buffer 
pH 6 .5
Extinction coefficients are in units of M'1 cm'
276 278 279 280 282
nm nm nm nm nm
Ext. coefficient 17400 16800 16140 15360 14400
Abs 0.1% (=1 g/1) 0.680 0.656 0.630 0.600 0.562
Estimated half-life:
The N-terminal of the sequence considered is M (Met).
The estimated half-life is: 30 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in v i vo).
>10 hours (Escherichia coli, in vivo).
Instability index:
The instability index (II) is computed to be 22.90 
This classifies the protein as stable.
Aliphatic index: 78.63
Grand average of hydropathicity (GRAVY): -0.765
          1
ExPASv Home page Site M ap Search ExPASv Contact us Swiss-Prot Proteoniics tools
I n f e c t i o n  a n d  I m m u n i ty ,  July 2004, p. 4261-4270
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.7.4261-4270.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Vol. 72, No. 7
Structural Relationships and Cellular Tropism of Staphylococcal 
Superantigen-Like Proteins
4261
4262 AI.-S HANG III ET AL. In f e c t . I m m u n .
V o l . 72, 2004 SSLs TARGET ANTIGEN-PRESENTING CELLS 4263
4264 AL-SHANGITI ET AL. In f e c t . Im m un .
V ol. 72. 2004 SSLs TARGET ANTIGEN-PRESENTING CELLS 4265
4266 AL-SHANGITI ET AL. In f e c t . Im m un .
Vol. 72, 2004 SSLs TARGET ANTIGEN-PRESENTING CELLS 4267
4268 AL-SHANGITI ET AL. In f e c t . Im m u n .
V ol. 72. 2004 SSLs TARGET ANTIGEN-PRESENTING CELLS 4269
4270 AL-SHANGITI ET AL. In f e c t . I m m u n .
Editor J. B. Bliska
